{"content":"<li class=\"n-box-item date-title\" data-end=\"1515128399\" data-start=\"1515042000\" data-txt=\"Monday, December 23, 2019\">Thursday, January  4, 2018</li><li class=\"n-box-item sa-box-item\" data-id=\"3321328\" data-ts=\"1515112195\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/AAPL\" target=\"_blank\">AAPL</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3321328-apple-confirms-all-devices-affected-processor-exploits\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Apple confirms all its devices affected by processor exploits</a></h4><ul>     <li>Apple (NASDAQ:<a href='https://seekingalpha.com/symbol/AAPL' title='Apple Inc.'>AAPL</a>) is confirming tonight that <a href=\"https://support.apple.com/en-us/HT208394\" target=\"_blank\">its devices are affected</a> by the much-discussed \"Spectre\" and \"Meltdown\" processor exploits, whose revelation has depressed Intel (NASDAQ:<a href='https://seekingalpha.com/symbol/INTC' title='Intel Corporation'>INTC</a>) stock for two days and given a boost to <a href='https://seekingalpha.com/symbol/AMD' title='Advanced Micro Devices, Inc.'>AMD</a>.</li>     <li>\"All Mac systems and iOS devices are affected, but there are no known exploits impacting customers at this time,\" the company says in a forum post. \"Since exploiting many of these issues requires a malicious app to be loaded on your Mac or iOS device, we recommend downloading software only from trusted sources such as the App Store.\"</li>     <li>The company plans mitigations \"in the coming days\" for Safari, to defend against Spectre, and says it's already released mitigations in iOS 11.2, macOS 10.13.2, and tvOS 11.2 to help defend against Meltdown.</li><li>Apple Watch isn't affected by Meltdown, the company says.</li>    <li>Apple shares are <font color='green'>up 0.1%</font> in after-hours action. <a href='https://seekingalpha.com/symbol/INTC' title='Intel Corporation'>INTC</a> <font color='red'>fell another 1.8%</font> today and is <font color='red'>down 0.3%</font> in postmarket trading; <a href='https://seekingalpha.com/symbol/AMD' title='Advanced Micro Devices, Inc.'>AMD</a> <font color='green'>rose another 4.9%</font> today and is <font color='green'>up 0.6%</font> after hours.</li><li>Previously: <a href=\"https://seekingalpha.com/news/3321278-intel-updates-flawed-chips-barclays-says-co-take-financial-hit\" target=\"_blank\">Intel updates flawed chips; Barclays says co. won't take financial hit</a> (Jan. 04 2018)</li><li>Previously: <a href=\"https://seekingalpha.com/news/3321179-tech-giants-scurry-patch-chip-flaws-intel-minus-2_6-percent\" target=\"_blank\">Tech giants scurry to patch chip flaws; Intel -2.6%</a> (Jan. 04 2018)</li> </ul><div class=\"tiny-share-widget\" data-id=\"3321328\" data-linked=\"Apple confirms all its devices affected by processor exploits\" data-tweet=\"$AAPL $AAPL $INTC - Apple confirms all its devices affected by processor exploits https://seekingalpha.com/news/3321328-apple-confirms-all-devices-affected-processor-exploits?source=tweet\" data-url=\"https://seekingalpha.com/news/3321328-apple-confirms-all-devices-affected-processor-exploits\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  7:29 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>245&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3321324\" data-ts=\"1515105516\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3321324-after-hours-gainers-losers\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">After Hours Gainers / Losers</a></h4><ul>     <li><b>Top gainers:</b> <a href='https://seekingalpha.com/symbol/CCIH' title='ChinaCache International'>CCIH</a> <font color='green'>+15.9%</font>. <a href='https://seekingalpha.com/symbol/CFMS' title='ConforMIS'>CFMS</a> <font color='green'>+13.4%</font>. <a href='https://seekingalpha.com/symbol/SONC' title='Sonic Corp.'>SONC</a> <font color='green'>+5.2%</font>. <a href='https://seekingalpha.com/symbol/AMRN' title='Amarin Corporation PLC'>AMRN</a> <font color='green'>+3.8%</font>. <a href='https://seekingalpha.com/symbol/IONS' title='Ionis Pharmaceuticals, Inc.'>IONS</a> <font color='green'>+3.1%</font>.</li><li><b>Top losers:</b> <a href='https://seekingalpha.com/symbol/RGNX' title='REGENXBIO'>RGNX</a> <font color='red'>-16.6%</font>. <a href='https://seekingalpha.com/symbol/FRAN' title='Francesca&#39;s Holdings Corp.'>FRAN</a> <font color='red'>-15.6%</font>. <a href='https://seekingalpha.com/symbol/SCYX' title='SCYNEXIS, Inc.'>SCYX</a> <font color='red'>-9.1%</font>. <a href='https://seekingalpha.com/symbol/SPWH' title='Sportsman&#39;s Warehouse Holdings, Inc.'>SPWH</a> <font color='red'>-3.9%</font>. <a href='https://seekingalpha.com/symbol/AUPH' title='Aurinia Pharmaceuticals Inc.'>AUPH</a> <font color='red'>-3.4%</font>.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3321324\" data-linked=\"After Hours Gainers / Losers\" data-tweet=\"$CCIH $CFMS $SONC - After Hours Gainers / Losers https://seekingalpha.com/news/3321324-after-hours-gainers-losers?source=tweet\" data-url=\"https://seekingalpha.com/news/3321324-after-hours-gainers-losers\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  5:38 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>4&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3321321\" data-ts=\"1515103462\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/AMRN\" target=\"_blank\">AMRN</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3321321-amarin-sees-230m-in-sales-this-year-shares-up-3-after-hours\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Amarin sees $230M in sales this year; shares up 3% after hours</a></h4><ul><li>Amarin (NASDAQ:<a href='https://seekingalpha.com/symbol/AMRN' title='Amarin Corporation PLC'>AMRN</a>) <a href=\"https://seekingalpha.com/pr/17038681-amarin-provides-preliminary-2017-results-provides-2018-outlook\" target=\"_blank\">updates investors</a> on Q4 and its outlook for 2018:</li><li><strong>2017</strong>: product revenue: $177M - 180M, including $51M - 54M in Q4. Wholesaler inventory levels of Vascepa within normal ranges at year-end. Accounts receivable: ~$44M (up 120% from a year ago and up 27% from Q3). Cash balance: $73.6M.</li><li><strong>2018 guidance</strong>: revenue: ~$230M, up ~30% each quarter. Guidance will be updated after REDUCE-IT results, expected in late Q3. Revenue this quarter should be $45M - 48M.</li></ul><div class=\"tiny-share-widget\" data-id=\"3321321\" data-linked=\"Amarin sees $230M in sales this year; shares up 3% after hours\" data-tweet=\"$AMRN - Amarin sees $230M in sales this year; shares up 3% after hours https://seekingalpha.com/news/3321321-amarin-sees-230m-in-sales-this-year-shares-up-3-after-hours?source=tweet\" data-url=\"https://seekingalpha.com/news/3321321-amarin-sees-230m-in-sales-this-year-shares-up-3-after-hours\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  5:04 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>3&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3321308\" data-ts=\"1515101368\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/RGNX\" target=\"_blank\">RGNX</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3321308-regenxbio-updates-on-pipeline-progress-provides-2018-guidance-shares-down-16-after-hours\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">REGENXBIO updates on pipeline progress, provides 2018 guidance; shares down 16% after hours</a></h4><ul><li>REGENXBIO (NASDAQ:<a href='https://seekingalpha.com/symbol/RGNX' title='REGENXBIO'>RGNX</a>) <a href=\"https://seekingalpha.com/pr/17038602-regenxbio-provides-year-end-2017-corporate-update\" target=\"_blank\">updates </a>investors on key clinical studies and provides guidance for this year.</li><li>RGX-314 for wet AMD: As of 12/31/17, 13 subjects treated with single dose, no drug-related serious adverse events reported. Third cohort treated.</li><li>RGX-501 for HoFH: As of 12/31, three patients treated. One experienced a serious adverse event (hypotension associated with a mild inflammatory response) which resolved a few hours after onset.</li><li>RGX-121 in MPS II: U.S. IND active. Phase 1/2 study will commence in H1.</li><li>Quick asset balance as of 12/31: $175M.</li><li><strong>2018 guidance</strong>:</li><li>RGX-314 in wet AMD: complete enrollment in Phase 1 study in H1. Present topline data in Q4.</li><li>RGX-501 in HoFH: complete enrollment in Phase 1/2 study mid-year. Present topline data in Q4.</li><li>RGX-111 in MPS I: begin enrollment in Phase 1 study in H1. Present interim data in Q4.</li><li>RGX-121 in MPS II: begin enrollment in Phase 1/2 study in H1. Present interim data in Q4.</li><li>A new pipeline candidate will be identified in H2.</li><li>Cash consumption: $85M - 95M.</li><li><strong>Update</strong>: Shares are down&nbsp;<font color='red'>16%</font>&nbsp;after hours on apparent disappointment with the timelines.</li></ul><div class=\"tiny-share-widget\" data-id=\"3321308\" data-linked=\"REGENXBIO updates on pipeline progress, provides 2018 guidance; shares down 16% after hours\" data-tweet=\"$RGNX - REGENXBIO updates on pipeline progress, provides 2018 guidance; shares down 16% after hours https://seekingalpha.com/news/3321308-regenxbio-updates-on-pipeline-progress-provides-2018-guidance-shares-down-16-after-hours?source=tweet\" data-url=\"https://seekingalpha.com/news/3321308-regenxbio-updates-on-pipeline-progress-provides-2018-guidance-shares-down-16-after-hours\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:29 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>2&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3321305\" data-ts=\"1515101124\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/SONC\" target=\"_blank\">SONC</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3321305-sonic-higher-on-solid-guidance\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Sonic higher on solid guidance</a></h4><ul>     <li>Sonic (NASDAQ:<a href='https://seekingalpha.com/symbol/SONC' title='Sonic Corp.'>SONC</a>) reports <a href=\"https://seekingalpha.com/news/3321293-sonic-beats-0_05-misses-revenue\" target=\"_blank\">FQ1</a> franchise comparable sales fell -1.6% in Q4 vs. consensus.</li>     <li>System-wide comparable sales were down -1.7% during the quarter vs. -1.4% consensus.</li>     <li>Payroll costs were flat compared to a year ago at 36.4% of sales.</li>     <li>Food and packaging costs were up 60 bps to 28.3% of sales.</li>     <li>Looking ahead, Sonic expects same-store sales growth of 0% to 2% for the system. The company sees 70 to 80 new franchise drive-in openings. A drive-in-level margin rate of of 15.1% to 15.7% is anticipated.</li><li>Previously: <a href=\"https://seekingalpha.com/news/3321293-sonic-beats-0_05-misses-revenue\" target=\"_blank\">Sonic beats by $0.05, misses on revenue</a> (Jan. 4)</li><li>SONC&nbsp;<font color='green'>+2.83%</font>&nbsp;AH to $28.35.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3321305\" data-linked=\"Sonic higher on solid guidance\" data-tweet=\"$SONC - Sonic higher on solid guidance https://seekingalpha.com/news/3321305-sonic-higher-on-solid-guidance?source=tweet\" data-url=\"https://seekingalpha.com/news/3321305-sonic-higher-on-solid-guidance\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:25 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3321299\" data-ts=\"1515100444\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/AAPL\" target=\"_blank\">AAPL</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3321299-apple-app-stores-record-breaking-holiday-season-included-300m-in-day\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Apple App Store&#39;s record-breaking holiday season included $300M in a day</a></h4><ul><li>        Apple (NASDAQ:<a href='https://seekingalpha.com/symbol/AAPL' title='Apple Inc.'>AAPL</a>) says the App Store had a <a href=\"https://seekingalpha.com/pr/17038553-app-store-kicks-2018-record-breaking-holiday-season\" target=\"_blank\">record-breaking</a> holiday season.</li><li>               Customers spent $890M in the seven-day period starting Christmas Eve. New Year&rsquo;s Day had $300M in purchases.&nbsp;</li><li>               In 2017, iOS developers earned $26.5B, up over 30% on the year.&nbsp;&nbsp;</li><li>Previously: <a href=\"https://seekingalpha.com/news/3321271-gbh-apple-repatriate-200b\" target=\"_blank\">GBH: Apple could repatriate $200B</a> (Jan. 4)</li></ul><div class=\"tiny-share-widget\" data-id=\"3321299\" data-linked=\"Apple App Store&#39;s record-breaking holiday season included $300M in a day\" data-tweet=\"$AAPL - Apple App Store&#39;s record-breaking holiday season included $300M in a day https://seekingalpha.com/news/3321299-apple-app-stores-record-breaking-holiday-season-included-300m-in-day?source=tweet\" data-url=\"https://seekingalpha.com/news/3321299-apple-app-stores-record-breaking-holiday-season-included-300m-in-day\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:14 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>68&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3321293\" data-ts=\"1515100224\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/SONC\" target=\"_blank\">SONC</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3321293-sonic-beats-0_05-misses-on-revenue\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Sonic beats by $0.05, misses on revenue</a></h4><ul><li>Sonic (NASDAQ:<a href='https://seekingalpha.com/symbol/SONC' title='Sonic Corp.'>SONC</a>): Q1 EPS of $0.30 <font color='green'>beats by $0.05</font>.</li><li>Revenue of $105.43M (-18.6% Y/Y) <font color='red'>misses by $2.57M</font>.</li><li>Shares <font color='green'>+3%</font>.</li><li><a href='https://seekingalpha.com/pr/17038614-sonic-reports-first-fiscal-quarter-2018-earnings-per-share-growth'>Press Release</a></li></ul><div class=\"tiny-share-widget\" data-id=\"3321293\" data-linked=\"Sonic beats by $0.05, misses on revenue\" data-tweet=\"$SONC - Sonic beats by $0.05, misses on revenue https://seekingalpha.com/news/3321293-sonic-beats-0_05-misses-on-revenue?source=tweet\" data-url=\"https://seekingalpha.com/news/3321293-sonic-beats-0_05-misses-on-revenue\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:10 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>5&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3321291\" data-ts=\"1515100129\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/AEHR\" target=\"_blank\">AEHR</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3321291-aehr-test-systems-beats-0_02-beats-on-revenue\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Aehr Test Systems beats by $0.02, beats on revenue</a></h4><ul><li>Aehr Test Systems (NASDAQ:<a href='https://seekingalpha.com/symbol/AEHR' title='Aehr Test Systems'>AEHR</a>): Q2 EPS of $0.02 <font color='green'>beats by $0.02</font>.</li><li>Revenue of $7.92M (+87.7% Y/Y) <font color='green'>beats by $0.81M</font>.</li><li>Shares <font color='green'>+6%</font>.</li><li><a href='https://seekingalpha.com/pr/17038606-aehr-test-systems-reports-88-percent-revenue-growth-second-quarter-fiscal-2018-reiterates'>Press Release</a></li></ul><div class=\"tiny-share-widget\" data-id=\"3321291\" data-linked=\"Aehr Test Systems beats by $0.02, beats on revenue\" data-tweet=\"$AEHR - Aehr Test Systems beats by $0.02, beats on revenue https://seekingalpha.com/news/3321291-aehr-test-systems-beats-0_02-beats-on-revenue?source=tweet\" data-url=\"https://seekingalpha.com/news/3321291-aehr-test-systems-beats-0_02-beats-on-revenue\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:08 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>10&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3321290\" data-ts=\"1515100119\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3321290-blizzard-plunging-temps-spark-natural-gas-spike\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Blizzard, plunging temps spark natural gas spike</a></h4><ul><li>To look at the futures market, things will be warming up soon - natural gas is&nbsp;<font color='red'>down 4.5%</font>&nbsp;on the session to $2.872. The spot market, however, is a far different story, <a href=\"https://www.bloomberg.com/news/articles/2018-01-04/natural-gas-in-u-s-soars-to-world-s-priciest-as-snow-slams-east?utm_content=tictoc&amp;utm_campaign=socialflow-organic&amp;utm_source=twitter&amp;utm_medium=social&amp;cmpid%3D=socialflow-twitter-tictoc\" target=\"_blank\">with prices today in </a>New York hitting 60x that amount, or a record $175 per million BTUs.</li><li>Other major trading hubs in the northeast saw similar spikes.</li><li>At issue isn't a lack of gas, but instead a lack of pipeline capacity to move product into the major population centers of the Northeast.</li><li>ETFs: <a href='https://seekingalpha.com/symbol/UNG' title='The United States Natural Gas ETF, LP'>UNG</a>, <a href='https://seekingalpha.com/symbol/UGAZ' title='VelocityShares 3x Long Natural Gas ETN'>UGAZ</a>, <a href='https://seekingalpha.com/symbol/DGAZ' title='VelocityShares 3x Inverse Natural Gas ETN'>DGAZ</a>, <a href='https://seekingalpha.com/symbol/BOIL' title='ProShares Ultra Bloomberg Natural Gas ETF'>BOIL</a>, <a href='https://seekingalpha.com/symbol/KOLD' title='ProShares UltraShort Bloomberg Natural Gas ETF'>KOLD</a>, <a href='https://seekingalpha.com/symbol/UNL' title='The United States 12 Month Natural Gas ETF, LP'>UNL</a>, <a href='https://seekingalpha.com/symbol/DCNG' title='iPath Pure Beta Seasonal Natural Gas ETN'>DCNG</a>, <a href='https://seekingalpha.com/symbol/GAZB' title='iPath Series B Bloomberg Natural Gas Subindex Total Return ETN'>GAZB</a></li></ul><div class=\"tiny-share-widget\" data-id=\"3321290\" data-linked=\"Blizzard, plunging temps spark natural gas spike\" data-tweet=\"$UNG $UGAZ $DGAZ - Blizzard, plunging temps spark natural gas spike https://seekingalpha.com/news/3321290-blizzard-plunging-temps-spark-natural-gas-spike?source=tweet\" data-url=\"https://seekingalpha.com/news/3321290-blizzard-plunging-temps-spark-natural-gas-spike\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:08 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>94&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3321286\" data-ts=\"1515098890\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/FB\" target=\"_blank\">FB</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3321286-zuckerbergs-2018-personal-challenge-involves-fb-fixes-and-cryptocurrency\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Zuckerberg&#39;s 2018 personal challenge involves FB fixes and cryptocurrency</a></h4><ul><li>        Facebook&rsquo;s (NASDAQ:<a href='https://seekingalpha.com/symbol/FB' title='Facebook'>FB</a>) Mark Zuckerberg sets a personal challenge at the start of every year and in 2018 that challenge includes a <a href=\"https://www.facebook.com/zuck/posts/10104380170714571\" target=\"_blank\">cryptocurrency mention</a>.</li><li>               Zuckerberg&rsquo;s overall challenge is to fix Facebook&rsquo;s &ldquo;important issues&rdquo; by meeting with experts to explore tech questions like decentralization versus centralization&nbsp;</li><li>               Key quote: &ldquo;With the rise of a small number of big tech companies &mdash; and governments using technology to watch their citizens &mdash; many people now believe technology only centralizes power rather than decentralizes it.&rdquo;&nbsp;</li><li>                  &rdquo;There are important counter-trends to this --like encryption and cryptocurrency -- that take power from centralized systems and put it back into people's hands. But they come with the risk of being harder to control. I'm interested to go deeper and study the positive and negative aspects of these technologies, and how best to use them in our services.&rdquo;   </li><li>               Related ticker: Bitcoin Investment Trust (<a href='https://seekingalpha.com/symbol/GBTC' title='Grayscale Bitcoin Trust &#40;BTC&#41;'>OTCQX:GBTC</a> <font color='red'>-0.9%</font>).&nbsp;</li><li>               Facebook shares are&nbsp;<font color='green'>up 0.1%</font>.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</li></ul><div class=\"tiny-share-widget\" data-id=\"3321286\" data-linked=\"Zuckerberg&#39;s 2018 personal challenge involves FB fixes and cryptocurrency\" data-tweet=\"$FB $FB $GBTC - Zuckerberg&#39;s 2018 personal challenge involves FB fixes and cryptocurrency https://seekingalpha.com/news/3321286-zuckerbergs-2018-personal-challenge-involves-fb-fixes-and-cryptocurrency?source=tweet\" data-url=\"https://seekingalpha.com/news/3321286-zuckerbergs-2018-personal-challenge-involves-fb-fixes-and-cryptocurrency\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  3:48 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>59&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3321283\" data-ts=\"1515097290\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/RNN\" target=\"_blank\">RNN</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3321283-new-president-finance-chief-rexahn-pharma-shares-up-4\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">New president &amp; finance chief at Rexahn Pharma; shares up 4%</a></h4><ul><li>Rexahn Pharmaceuticals (<a href='https://seekingalpha.com/symbol/RNN' title='Rexahn Pharmaceuticals Inc'>RNN</a> <font color='green'>+4.3%</font>) <a href=\"https://seekingalpha.com/pr/17038092-rexahn-pharmaceuticals-announces-appointment-douglas-j-swirsky-president-chief-financial\" target=\"_blank\">appoints </a>Douglas Swirsky as President and Chief Financial Officer effective today. Previously, he was President &amp; CEO at GenVec.</li></ul><div class=\"tiny-share-widget\" data-id=\"3321283\" data-linked=\"New president &amp; finance chief at Rexahn Pharma; shares up 4%\" data-tweet=\"$RNN $REXN - New president &amp; finance chief at Rexahn Pharma; shares up 4% https://seekingalpha.com/news/3321283-new-president-finance-chief-rexahn-pharma-shares-up-4?source=tweet\" data-url=\"https://seekingalpha.com/news/3321283-new-president-finance-chief-rexahn-pharma-shares-up-4\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  3:21 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3321280\" data-ts=\"1515096971\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/KO\" target=\"_blank\">KO</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3321280-credit-suisse-makes-huge-call-on-beverage-stocks\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Credit Suisse makes huge call on beverage stocks</a></h4><ul><li>Coca-Cola (<a href='https://seekingalpha.com/symbol/KO' title='The Coca-Cola Company'>KO</a> <font color='green'>+1.2%</font>) tracks higher after Credit Suisse names the beverage stock one of its top picks for 2018.</li><li>Analyst Laurent Grandet expects the new asset-light model at Coca-Cola to help it deliver 10% EPS growth in 2019.</li><li>The CS team also issues some \"blue sky\" scenarios on Monster Beverage (<a href='https://seekingalpha.com/symbol/MNST' title='Monster Beverage Corp.'>MNST</a> <font color='green'>+0.1%</font>) and Dr Pepper Snapple (<a href='https://seekingalpha.com/symbol/DPS-OLD' title='Dr Pepper Snapple Group, Inc.'>DPS-OLD</a> <font color='green'>+0.7%</font>) as it factors in tax reform benefits. Under the best case CS model, Monster is seen running up 32% to $83, while Dr Pepper Snapple could jump 33% to $12.</li></ul><div class=\"tiny-share-widget\" data-id=\"3321280\" data-linked=\"Credit Suisse makes huge call on beverage stocks\" data-tweet=\"$KO $KO $MNST - Credit Suisse makes huge call on beverage stocks https://seekingalpha.com/news/3321280-credit-suisse-makes-huge-call-on-beverage-stocks?source=tweet\" data-url=\"https://seekingalpha.com/news/3321280-credit-suisse-makes-huge-call-on-beverage-stocks\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  3:16 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>12&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3321279\" data-ts=\"1515096958\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/PFNX\" target=\"_blank\">PFNX</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3321279-new-finance-chief-pfenex-shares-up-6\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">New finance chief at Pfenex; shares up 6%</a></h4><ul><li>Pfenex (<a href='https://seekingalpha.com/symbol/PFNX' title='Pfenex'>PFNX</a> <font color='green'>+5.7%</font>) <a href=\"https://seekingalpha.com/pr/17037817-pfenex-names-susan-knudson-chief-financial-officer\" target=\"_blank\">appoints</a> Susan Knudson as CFO effective February 1. She succeeds Paul Wagner who resigned in October. Previously, she was CFO at Neothetics.</li></ul><div class=\"tiny-share-widget\" data-id=\"3321279\" data-linked=\"New finance chief at Pfenex; shares up 6%\" data-tweet=\"$PFNX - New finance chief at Pfenex; shares up 6% https://seekingalpha.com/news/3321279-new-finance-chief-pfenex-shares-up-6?source=tweet\" data-url=\"https://seekingalpha.com/news/3321279-new-finance-chief-pfenex-shares-up-6\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  3:15 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3321278\" data-ts=\"1515096727\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/INTC\" target=\"_blank\">INTC</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3321278-intel-updates-flawed-chips-barclays-says-co-wont-take-financial-hit\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Intel updates flawed chips; Barclays says co. won&#39;t take financial hit</a></h4><ul><li>        Intel (NASDAQ:<a href='https://seekingalpha.com/symbol/INTC' title='Intel Corporation'>INTC</a>) <a href=\"https://www.cnbc.com/2018/01/04/intel-says-it-has-issued-updates-for-most-chips-from-past-5-years.html\" target=\"_blank\">says</a> it has &ldquo;already issued updates for processor products introduced within the past five years.&rdquo;</li><li>        The company plans to have issued updates for over 90% of those processor products by the end of next week.</li><li>               Barclay analysts <a href=\"https://9to5mac.com/2018/01/04/cpu-flaw-wont-affect-intel/\" target=\"_blank\">don&rsquo;t expect</a> Intel to take a financial hit from the chip vulnerability.&nbsp;</li><li>               The firm says flaws happen in CPU architectures from time to time, get resolved, and then everyone moves on.&nbsp;</li><li>               Intel shares are&nbsp;<font color='red'>down 2.9%</font>.&nbsp;&nbsp;&nbsp;&nbsp;</li><li>Previously: <a href=\"https://seekingalpha.com/news/3321179-tech-giants-scurry-patch-chip-flaws-intel-minus-2_6-percent\" target=\"_blank\">Tech giants scurry to patch chip flaws; Intel -2.6%</a> (Jan. 4)</li></ul><div class=\"tiny-share-widget\" data-id=\"3321278\" data-linked=\"Intel updates flawed chips; Barclays says co. won&#39;t take financial hit\" data-tweet=\"$INTC - Intel updates flawed chips; Barclays says co. won&#39;t take financial hit https://seekingalpha.com/news/3321278-intel-updates-flawed-chips-barclays-says-co-wont-take-financial-hit?source=tweet\" data-url=\"https://seekingalpha.com/news/3321278-intel-updates-flawed-chips-barclays-says-co-wont-take-financial-hit\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  3:12 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>143&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3321273\" data-ts=\"1515095706\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3321273-technology-top-gainers-losers-of-2-55-pm\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Technology - Top Gainers / Losers as of 2:55 pm</a></h4><ul>     <li><b>Gainers:</b> <a href='https://seekingalpha.com/symbol/CMCM' title='Cheetah Mobile Inc.'>CMCM</a> <font color='green'>+23%</font>. <a href='https://seekingalpha.com/symbol/TCCO' title='Technical Communications Corp.'>TCCO</a> <font color='green'>+20%</font>. <a href='https://seekingalpha.com/symbol/SQNS' title='Sequans Communications'>SQNS</a> <font color='green'>+20%</font>. <a href='https://seekingalpha.com/symbol/IZEA' title='IZEA Worldwide, Inc.'>IZEA</a> <font color='green'>+18%</font>. <a href='https://seekingalpha.com/symbol/XNET' title='Xunlei Limited'>XNET</a> <font color='green'>+15%</font>.</li><li><b>Losers:</b> <a href='https://seekingalpha.com/symbol/RENN' title='Renren Inc.'>RENN</a> <font color='red'>-17%</font>. <a href='https://seekingalpha.com/symbol/ESIO' title='Electro Scientific Industries, Inc.'>ESIO</a> <font color='red'>-12%</font>. <a href='https://seekingalpha.com/symbol/NETE' title='Net Element International, Inc.'>NETE</a> <font color='red'>-8%</font>. <a href='https://seekingalpha.com/symbol/LEDS' title='SemiLEDs Corporation'>LEDS</a> <font color='red'>-7%</font>. <a href='https://seekingalpha.com/symbol/LIVE' title='Live Ventures'>LIVE</a> <font color='red'>-7%</font>.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3321273\" data-linked=\"Technology - Top Gainers / Losers as of 2:55 pm\" data-tweet=\"$CMCM $TCCO $SQNS - Technology - Top Gainers / Losers as of 2:55 pm https://seekingalpha.com/news/3321273-technology-top-gainers-losers-of-2-55-pm?source=tweet\" data-url=\"https://seekingalpha.com/news/3321273-technology-top-gainers-losers-of-2-55-pm\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  2:55 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>6&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3321274\" data-ts=\"1515095549\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/LRAD\" target=\"_blank\">LRAD</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3321274-lrad-corporation-receives-follow-on-public-safety-orders-from-asia-pacific-region\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">LRAD Corporation Receives Follow-On Public Safety Orders from Asia Pacific Region</a></h4><ul>     <li>LRAD Corporation (<a href='https://seekingalpha.com/symbol/LRAD' title='LRAD Corp'>LRAD</a> <font color='green'>+3.1%</font>) announced $0.895M in follow-on AHD orders from the Asia Pacific region. The orders are scheduled to ship in the Company's current fiscal year.</li>     <li>&ldquo;LRAD's superior broadcast range, vocal clarity, and durability continue to drive follow-on orders. The AHDs in these orders will be vehicle mounted and provide law enforcement a critical communications capability for everyday duties and elevated risk operations,&rdquo; noted Richard S. Danforth, Chief Executive Officer of LRAD Corporation. &ldquo;Public safety agencies in Asia and throughout the world are making LRAD their communication system of choice.&rdquo;</li><li><a href=\"https://seekingalpha.com/pr/17038083-lrad-corporation-receives-895000-follow-public-safety-orders-asia-pacific-region\" target=\"_blank\">Press Release</a></li> </ul><div class=\"tiny-share-widget\" data-id=\"3321274\" data-linked=\"LRAD Corporation Receives Follow-On Public Safety Orders from Asia Pacific Region\" data-tweet=\"$LRAD $GNSS - LRAD Corporation Receives Follow-On Public Safety Orders from Asia Pacific Region https://seekingalpha.com/news/3321274-lrad-corporation-receives-follow-on-public-safety-orders-from-asia-pacific-region?source=tweet\" data-url=\"https://seekingalpha.com/news/3321274-lrad-corporation-receives-follow-on-public-safety-orders-from-asia-pacific-region\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  2:52 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3321271\" data-ts=\"1515094480\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/AAPL\" target=\"_blank\">AAPL</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3321271-gbh-apple-repatriate-200b\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">GBH: Apple could repatriate $200B</a></h4><ul><li>        GBH <a href=\"https://9to5mac.com/2018/01/04/apple-foreign-cash-repatriation/\" target=\"_blank\">estimates</a> that Apple (NASDAQ:<a href='https://seekingalpha.com/symbol/AAPL' title='Apple Inc.'>AAPL</a>) will repatriate around $200B of its foreign cash under the new U.S. tax code.</li><li>               Apple has $252B in foreign cash.&nbsp;</li><li>               GBH outlines three ways Apple could spend the money: accelerate buybacks, another dividend hike, and potential larger M&amp;A. &nbsp;&nbsp;&nbsp;</li><li>               The firm thinks Apple will likely keep M&amp;A deals under $2B, but &ldquo;strongly believe&rdquo; it&rsquo;s time for Apple to make a bigger investment in a new growth area such as Netflix and streaming video.&nbsp;</li><li>               Apple shares are&nbsp;<font color='green'>up 0.42%</font>. &nbsp;&nbsp; &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</li><li>Previously: <a href=\"https://seekingalpha.com/news/3321190-digitimes-tsmc-will-supply-a12-processors-next-iphones\" target=\"_blank\">DigiTimes: TSMC will supply A12 processors for next iPhones</a> (Jan. 4)</li><li>Previously: <a href=\"https://seekingalpha.com/news/3321218-oppenheimer-large-cap-revenue-etf-rwl-december-summary\" target=\"_blank\">Oppenheimer Large Cap Revenue ETF (NYSEARCA:<a href='https://seekingalpha.com/symbol/RWL-OLD' title='Oppenheimer Large Cap Revenue ETF'>RWL-OLD</a>) December Summary</a> (Jan. 4)</li></ul><div class=\"tiny-share-widget\" data-id=\"3321271\" data-linked=\"GBH: Apple could repatriate $200B\" data-tweet=\"$AAPL $AAPL $RWL-OLD - GBH: Apple could repatriate $200B https://seekingalpha.com/news/3321271-gbh-apple-repatriate-200b?source=tweet\" data-url=\"https://seekingalpha.com/news/3321271-gbh-apple-repatriate-200b\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  2:34 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>87&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3321268\" data-ts=\"1515092901\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/APO\" target=\"_blank\">APO</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3321268-onemain-financial-soars-25-after-apollo-buys-in\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">OneMain Financial soars 25% after Apollo buys in</a></h4><ul><li>Reported on last night and made official this morning, Apollo Global (<a href='https://seekingalpha.com/symbol/APO' title='Apollo Global Management, LLC'>APO</a> <font color='green'>+0.4%</font>) and Varde Partners are paying funds managed by Fortress Investment (NYSE:<a href='https://seekingalpha.com/symbol/FIG' title='Fortress Investment Group LLC'>FIG</a>) $26 per share for their 40.5% stake in OneMain Financial (<a href='https://seekingalpha.com/symbol/OMF' title='OneMain Holdings, Inc.'>OMF</a> <font color='green'>+25.3%</font>).</li><li>The deal is seen closing in Q2.</li><li>OneMain was subsequently upgraded to Buy with $34 price target at Compass Point. The rise today brings the stock price to $33.39.</li><li>Source: <a href=\"https://seekingalpha.com/pr/17037595-investor-group-led-funds-managed-affiliates-apollo-global-management-varde-partners-acquire\" target=\"_blank\">Press Release</a></li><li>Previously: <a href=\"https://seekingalpha.com/news/3321063-reuters-apollo-nears-deal-fortress-stake-onemain\" target=\"_blank\">Reuters: Apollo nears deal for Fortress' stake in OneMain</a> (Jan. 3)</li></ul><div class=\"tiny-share-widget\" data-id=\"3321268\" data-linked=\"OneMain Financial soars 25% after Apollo buys in\" data-tweet=\"$APO $APO $FIG - OneMain Financial soars 25% after Apollo buys in https://seekingalpha.com/news/3321268-onemain-financial-soars-25-after-apollo-buys-in?source=tweet\" data-url=\"https://seekingalpha.com/news/3321268-onemain-financial-soars-25-after-apollo-buys-in\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  2:08 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3321265\" data-ts=\"1515092504\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3321265-energy-materials-top-gainers-losers-of-2-00-pm\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Energy/Materials - Top Gainers / Losers as of 2:00 pm</a></h4><ul>     <li><b>Gainers:</b> <a href='https://seekingalpha.com/symbol/MCEP' title='Mid-Con Energy Partners'>MCEP</a> <font color='green'>+30%</font>. <a href='https://seekingalpha.com/symbol/RCON' title='Recon Technology, Ltd.'>RCON</a> <font color='green'>+14%</font>. <a href='https://seekingalpha.com/symbol/YUMA' title='Yuma Energy, Inc.'>YUMA</a> <font color='green'>+9%</font>. <a href='https://seekingalpha.com/symbol/GBR' title='New Concept Energy, Inc.'>GBR</a> <font color='green'>+9%</font>. <a href='https://seekingalpha.com/symbol/TGB' title='Taseko Mines Limited'>TGB</a> <font color='green'>+9%</font>.</li><li><b>Losers:</b> <a href='https://seekingalpha.com/symbol/REXX' title='Rex Energy Corporation'>REXX</a> <font color='red'>-19%</font>. <a href='https://seekingalpha.com/symbol/LTBR' title='Lightbridge Corp'>LTBR</a> <font color='red'>-8%</font>. <a href='https://seekingalpha.com/symbol/IGC' title='India Globalization Capital, Inc'>OTC:IGC</a> <font color='red'>-8%</font>. <a href='https://seekingalpha.com/symbol/RYAM' title='Rayonier Advanced Materials'>RYAM</a> <font color='red'>-6%</font>. <a href='https://seekingalpha.com/symbol/SAEX' title='SAExploration Holdings, Inc.'>SAEX</a> <font color='red'>-5%</font>.</li></ul><div class=\"tiny-share-widget\" data-id=\"3321265\" data-linked=\"Energy/Materials - Top Gainers / Losers as of 2:00 pm\" data-tweet=\"$MCEP $RCON $YUMA - Energy/Materials - Top Gainers / Losers as of 2:00 pm https://seekingalpha.com/news/3321265-energy-materials-top-gainers-losers-of-2-00-pm?source=tweet\" data-url=\"https://seekingalpha.com/news/3321265-energy-materials-top-gainers-losers-of-2-00-pm\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  2:01 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>16&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3321263\" data-ts=\"1515092381\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/VIVE\" target=\"_blank\">VIVE</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3321263-viveve-medical-reports-q4-preliminary-results-sharesminus-4\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Viveve Medical reports Q4 preliminary results; shares -4%</a></h4><ul>     <li>Viveve Medical (<a href='https://seekingalpha.com/symbol/VIVE' title='Viveve Medical, Inc.'>VIVE</a> <font color='red'>-4%</font>)&nbsp;<a href=\"https://seekingalpha.com/pr/17037909-viveve-announces-preliminary-2017-fourth-quarter-year-end-financial-results-provides-2018\" target=\"_blank\">expects</a> Q4 sales of ~5.1M (+108% Y/Y) vs. a consensus of 5.25M.</li>     <li>The company expects FY17 sales of ~15.3M vs. a consensus of $15.51M.</li>     <li>Cash and cash equivalents were ~$20.4M as of Dec. 31, 2017.</li>     <li>The company plans to report its Q4 results in March 2018.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3321263\" data-linked=\"Viveve Medical reports Q4 preliminary results; shares -4%\" data-tweet=\"$VIVE - Viveve Medical reports Q4 preliminary results; shares -4% https://seekingalpha.com/news/3321263-viveve-medical-reports-q4-preliminary-results-sharesminus-4?source=tweet\" data-url=\"https://seekingalpha.com/news/3321263-viveve-medical-reports-q4-preliminary-results-sharesminus-4\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  1:59 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3321260\" data-ts=\"1515091459\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/FOMX\" target=\"_blank\">FOMX</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3321260-foamix-pharmas-fmx101-well-tolerated-in-safety-study-shares-up-14\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Foamix Pharma&#39;s FMX101 well-tolerated in safety study; shares up 14%</a></h4><ul><li>Thinly traded Foamix Pharmaceuticals (<a href='https://seekingalpha.com/symbol/FOMX' title='Foamix Pharmaceuticals'>FOMX</a> <font color='green'>+13.9%</font>) is up on average volume, 68K shares, on the heels of its <a href=\"https://seekingalpha.com/pr/17037826-foamix-announces-positive-results-phase-3-open-label-safety-extension-evaluating-fmxminus-101\" target=\"_blank\">announcement </a>positive&nbsp;results from a Phase 3 open-label safety extension study evaluating FMX101 in people with moderate-to-severe acne over a treatment period of up to one year.</li><li>The 657 participants completed 12 weeks of treatment with FMX101 in preceding studies and continued treatment for an additional 40 weeks.</li><li>At week 52, more than 95% of subjects reported \"none\" or \"mild\" signs and symptoms (skin dryness or reddening, hyperpigmentation, peeling, itching). There were four discontinuations due to application site reactions. Patient satisfaction remained high from week 12 to week 52.</li><li>The results will be presented at the Winter Clinical Dermatology Conference in Hawaii, January 12 - 17.</li><li><a href=\"http://foamix.com/FMX101\" target=\"_blank\">FMX101 </a>is a proprietary 4% minocycline (antibiotic) foam formulation.</li><li>Previously: <a href=\"https://seekingalpha.com/news/3253525-foamix-pharmas-fmx101-shows-mixed-results-two-late-stage-acne-studies-shares-plummet-47\" target=\"_blank\">Foamix Pharma's FMX101 shows mixed results in two late-stage acne studies; shares plummet 47% premarket</a> (March 27, 2017)</li></ul><div class=\"tiny-share-widget\" data-id=\"3321260\" data-linked=\"Foamix Pharma&#39;s FMX101 well-tolerated in safety study; shares up 14%\" data-tweet=\"$FOMX - Foamix Pharma&#39;s FMX101 well-tolerated in safety study; shares up 14% https://seekingalpha.com/news/3321260-foamix-pharmas-fmx101-well-tolerated-in-safety-study-shares-up-14?source=tweet\" data-url=\"https://seekingalpha.com/news/3321260-foamix-pharmas-fmx101-well-tolerated-in-safety-study-shares-up-14\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  1:44 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>4&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3321258\" data-ts=\"1515090121\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/EARS\" target=\"_blank\">EARS</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3321258-additional-data-from-failed-late-stage-study-of-aurisminus-111-fails-to-excite-investors\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Additional data from the failed late-stage study of Auris&#39; AM-111 fails to excite investors, shares down 14%</a></h4><ul><li>Nano cap Auris Medical (<a href='https://seekingalpha.com/symbol/EARS' title='Auris Medical Holding'>EARS</a> <font color='red'>-14%</font>) slumps on increased volume despite management's <a href=\"https://seekingalpha.com/pr/17037912-auris-medical-provides-updateminus-111-development-program\" target=\"_blank\">presentation </a>of what it believes is encouraging data from the failed Phase 3 HEALOS study that evaluated AM-111 for the treatment of acute inner ear hearing loss.</li><li>AM-111, a biodegradable gel containing a peptide that inhibits an enzyme activated following inner ear stress, failed to sufficiently separate from placebo in the overall population, but did so in a subgroup of patients with profound hearing loss.</li><li>Data from 31 additional patients with profound hearing loss in a similar study, ASSENT, should be available in late March.</li><li>Management plans to meet with the FDA and EMA in Q2 to review the results and clarify a regulatory pathway. The data will also be submitted for presentation at a future medical conference and for publication.</li><li>Previously: <a href=\"https://seekingalpha.com/news/3314680-auris-medicalsminus-111-flunks-late-stage-study-acute-inner-ear-hearing-loss-shares-49\" target=\"_blank\">Auris Medical's AM-111 flunks late-stage study in acute inner ear hearing loss; shares down 49% premarket</a> (Nov. 28, 2017)</li></ul><div class=\"tiny-share-widget\" data-id=\"3321258\" data-linked=\"Additional data from the failed late-stage study of Auris&#39; AM-111 fails to excite investors, shares down 14%\" data-tweet=\"$EARS - Additional data from the failed late-stage study of Auris&#39; AM-111 fails to excite investors, shares down 14% https://seekingalpha.com/news/3321258-additional-data-from-failed-late-stage-study-of-aurisminus-111-fails-to-excite-investors?source=tweet\" data-url=\"https://seekingalpha.com/news/3321258-additional-data-from-failed-late-stage-study-of-aurisminus-111-fails-to-excite-investors\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  1:22 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>2&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3321257\" data-ts=\"1515089444\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/CRM\" target=\"_blank\">CRM</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3321257-salesforce-sets-60b-revenue-goal-for-2028\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Salesforce sets $60B revenue goal for 2028</a></h4><ul><li>        Salesforce (NYSE:<a href='https://seekingalpha.com/symbol/CRM' title='Salesforce.com, Inc.'>CRM</a>) plans to hit a $60B revenue goal by 2034, according to an investor <a href=\"https://twitter.com/BrentLeary/status/948950294205026304\" target=\"_blank\">presentation slide</a> posted on Twitter.</li><li>               The slide is credited to a presentation by CTO and co-founder Parker Harris and outlines Salesforce&rsquo;s revenue goals in a chapter structure.&nbsp;</li><li>               Chapter 3 starts in 2018 with the goal of reaching $20B before 2022.&nbsp;</li><li>               Chapter 4 goes from 2022 to 2028 with a $40B goal.&nbsp;</li><li>               Chapter 5 covers 2028 to 2034 with the $60B goal.&nbsp;</li><li>               Salesforce&rsquo;s FY18 guidance has revenue from $10.43B to $10.44B.&nbsp;</li><li>               Salesforce shares are&nbsp;<font color='green'>up 0.9%</font>. &nbsp;&nbsp; &nbsp;&nbsp;&nbsp;</li><li>Previously: <a href=\"https://seekingalpha.com/news/3320664-information-amazon-salesforce-seeking-oracle-alternatives\" target=\"_blank\">The Information: Amazon, Salesforce seeking Oracle alternatives</a> (Jan. 2)</li></ul><div class=\"tiny-share-widget\" data-id=\"3321257\" data-linked=\"Salesforce sets $60B revenue goal for 2028\" data-tweet=\"$CRM - Salesforce sets $60B revenue goal for 2028 https://seekingalpha.com/news/3321257-salesforce-sets-60b-revenue-goal-for-2028?source=tweet\" data-url=\"https://seekingalpha.com/news/3321257-salesforce-sets-60b-revenue-goal-for-2028\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  1:10 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>10&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3321256\" data-ts=\"1515089367\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/ENR\" target=\"_blank\">ENR</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3321256-energizer-rallies-deutsche-bank-points-to-multiple-drivers\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Energizer rallies as Deutsche Bank points to multiple drivers</a></h4><ul><li>Energizer Holdings (<a href='https://seekingalpha.com/symbol/ENR' title='Energizer Holdings, Inc.'>ENR</a> <font color='green'>+6.2%</font>) shoots higher after Deutsche Bank upgrades the consumer products seller to Buy from Neutral.</li><li>The company's retail and online execution as cited as a positive, while DB also thinks that Energizer is an under-appreciated tax reform beneficiary.</li><li>The kicker in the DB upgrade might be that Energizer is seen as the logical candidate to buy Spectrum Brands' battery business.</li><li>The price target on Energizer is pushed up to $58.</li></ul><div class=\"tiny-share-widget\" data-id=\"3321256\" data-linked=\"Energizer rallies as Deutsche Bank points to multiple drivers\" data-tweet=\"$ENR - Energizer rallies as Deutsche Bank points to multiple drivers https://seekingalpha.com/news/3321256-energizer-rallies-deutsche-bank-points-to-multiple-drivers?source=tweet\" data-url=\"https://seekingalpha.com/news/3321256-energizer-rallies-deutsche-bank-points-to-multiple-drivers\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  1:09 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>7&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3321254\" data-ts=\"1515089264\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3321254-financials-top-5-gainers-losers-of-1-00-pm\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Financials - Top 5 Gainers / Losers as of 1:00 PM</a></h4><ul><li><b>Gainers:</b> <a href='https://seekingalpha.com/symbol/OMF' title='OneMain Holdings, Inc.'>OMF</a> <font color='green'>+24%</font>. <a href='https://seekingalpha.com/symbol/CCCR-OLD' title='China Commercial Credit'>CCCR-OLD</a> <font color='green'>+20%</font>.<a href='https://seekingalpha.com/symbol/ARCT' title='Arcturus Therapeutics Ltd.'>ARCT</a> <font color='green'>+14%</font>. <a href='https://seekingalpha.com/symbol/CARV' title='Carver Bancorp, Inc.'>CARV</a> <font color='green'>+11%</font>. <a href='https://seekingalpha.com/symbol/UNAM' title='Unico American Corporation'>UNAM</a> <font color='green'>+10%</font>.</li><li><b>Losers:</b> <a href='https://seekingalpha.com/symbol/HGSH' title='China HGS Real Estate, Inc.'>HGSH</a> <font color='red'>-16%</font>. <a href='https://seekingalpha.com/symbol/IIPR' title='Innovative Industrial Properties'>IIPR</a> <font color='red'>-14%</font>. <a href='https://seekingalpha.com/symbol/GCAP' title='GAIN Capital Holdings, Inc.'>GCAP</a> <font color='red'>-7%</font>. <a href='https://seekingalpha.com/symbol/NHLD' title='National Holdings Corp.'>NHLD</a> <font color='red'>-5%</font>. <a href='https://seekingalpha.com/symbol/GROW' title='U.S. Global Investors, Inc.'>GROW</a> <font color='red'>-5%</font>.</li></ul><div class=\"tiny-share-widget\" data-id=\"3321254\" data-linked=\"Financials - Top 5 Gainers / Losers as of 1:00 PM\" data-tweet=\"$OMF $CCCR-OLD $ARCT - Financials - Top 5 Gainers / Losers as of 1:00 PM https://seekingalpha.com/news/3321254-financials-top-5-gainers-losers-of-1-00-pm?source=tweet\" data-url=\"https://seekingalpha.com/news/3321254-financials-top-5-gainers-losers-of-1-00-pm\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  1:07 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3321253\" data-ts=\"1515088849\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/TGNA\" target=\"_blank\">TGNA</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3321253-tegnaplus-1_6-wells-fargo-rates-outperform-on-upside\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Tegna +1.6% as Wells Fargo rates Outperform on upside</a></h4><ul>   <li>Tegna (NYSE:<a href='https://seekingalpha.com/symbol/TGNA' title='TEGNA'>TGNA</a>) is <font color='green'>up 1.6%</font> after an upgrade to Outperform at Wells Fargo.</li>    <li>Analyst Marci Ryvicker boosted the price target on the company to $19 from $14, implying 32% upside from today's price.</li>    <li>Between the broadcast group's exposure to upcoming Super Bowl and Olympics on NBC and a political spending uptick expected for some contentious midterm elections this fall, she sees heavy potential upside.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3321253\" data-linked=\"Tegna +1.6% as Wells Fargo rates Outperform on upside\" data-tweet=\"$TGNA - Tegna +1.6% as Wells Fargo rates Outperform on upside https://seekingalpha.com/news/3321253-tegnaplus-1_6-wells-fargo-rates-outperform-on-upside?source=tweet\" data-url=\"https://seekingalpha.com/news/3321253-tegnaplus-1_6-wells-fargo-rates-outperform-on-upside\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  1:00 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>2&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3321251\" data-ts=\"1515088675\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/SFIX\" target=\"_blank\">SFIX</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3321251-stitch-fixplus-5-on-down-day-for-brick-and-mortar-apparel\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Stitch Fix +5% on down day for brick-and-mortar apparel</a></h4><ul><li>Stitch Fix (NASDAQ:<a href='https://seekingalpha.com/symbol/SFIX' title='Stitch Fix, Inc.'>SFIX</a>) is back over $25 with a strong&nbsp;<font color='green'>5% move&nbsp;</font>today.</li><li>The bounce is running counter to the down day across the apparel store sector.</li><li>Clothing subscription specialist Stitch Fix is reportedly using higher and lower price points to appeal to different demographics.</li><li>Stitch Fix is still looked at favorably by Wall Street analysts despite the earnings miss with its first report as a publicly-traded company.</li><li>Previously: <a href=\"https://seekingalpha.com/news/3321209-jittery-trading-apparel-store-stocks\" target=\"_blank\">Jittery trading on apparel store stocks</a> (Jan. 4)</li></ul><div class=\"tiny-share-widget\" data-id=\"3321251\" data-linked=\"Stitch Fix +5% on down day for brick-and-mortar apparel\" data-tweet=\"$SFIX - Stitch Fix +5% on down day for brick-and-mortar apparel https://seekingalpha.com/news/3321251-stitch-fixplus-5-on-down-day-for-brick-and-mortar-apparel?source=tweet\" data-url=\"https://seekingalpha.com/news/3321251-stitch-fixplus-5-on-down-day-for-brick-and-mortar-apparel\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 12:57 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>6&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3321246\" data-ts=\"1515087637\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/PBPB\" target=\"_blank\">PBPB</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3321246-potbelly-in-play\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Potbelly in play?</a></h4><ul>     <li>Potbelly (<a href='https://seekingalpha.com/symbol/PBPB' title='Potbelly Corporation'>PBPB</a> <font color='green'>+0.8%</font>) has received interest from private equity firms, sources tip <a href=\"https://twitter.com/rorol/status/948942449103261696\" target=\"_blank\">The Deal's</a>&nbsp;Ronald Orol.</li>     <li>Offers in the mid-teens share price range have reportedly been received.</li>     <li>\"But will $PBPB agree to sell itself under pressure from an activist now that it has appointed a new CEO?,\" asks Orol.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3321246\" data-linked=\"Potbelly in play?\" data-tweet=\"$PBPB - Potbelly in play? https://seekingalpha.com/news/3321246-potbelly-in-play?source=tweet\" data-url=\"https://seekingalpha.com/news/3321246-potbelly-in-play\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 12:40 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>2&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3321245\" data-ts=\"1515087633\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3321245-midday-gainers-losers\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Midday Gainers / Losers</a></h4><ul>     <li><b>Gainers:</b> <a href='https://seekingalpha.com/symbol/CNET' title='ChinaNet Online Holdings, Inc.'>CNET</a> <font color='green'>+315%</font>. <a href='https://seekingalpha.com/symbol/APOP' title='Cellect Biotechnology Ltd.'>APOP</a> <font color='green'>+48%</font>. <a href='https://seekingalpha.com/symbol/HTGM' title='HTG Molecular Diagnostics'>HTGM</a> <font color='green'>+42%</font>. <a href='https://seekingalpha.com/symbol/AEMD' title='Aethlon Medical, Inc.'>AEMD</a> <font color='green'>+42%</font>. <a href='https://seekingalpha.com/symbol/CCXI' title='ChemoCentryx'>CCXI</a> <font color='green'>+34%</font>. <a href='https://seekingalpha.com/symbol/OMF' title='OneMain Holdings, Inc.'>OMF</a> <font color='green'>+24%</font>. <a href='https://seekingalpha.com/symbol/CMCM' title='Cheetah Mobile Inc.'>CMCM</a> <font color='green'>+20%</font>. <a href='https://seekingalpha.com/symbol/CCCR-OLD' title='China Commercial Credit'>CCCR-OLD</a> <font color='green'>+18%</font>. <a href='https://seekingalpha.com/symbol/TCCO' title='Technical Communications Corp.'>TCCO</a> <font color='green'>+17%</font>. <a href='https://seekingalpha.com/symbol/APHB' title='AmpliPhi Biosciences Corp.'>APHB</a> <font color='green'>+17%</font>.</li><li><b>Losers:</b> <a href='https://seekingalpha.com/symbol/AQB' title='AquaBounty Technologies, Inc.'>AQB</a> <font color='red'>-19%</font>. <a href='https://seekingalpha.com/symbol/HGSH' title='China HGS Real Estate, Inc.'>HGSH</a> <font color='red'>-17%</font>. <a href='https://seekingalpha.com/symbol/PXS' title='Pyxis Tankers Inc.'>PXS</a> <font color='red'>-16%</font>. <a href='https://seekingalpha.com/symbol/IIPR' title='Innovative Industrial Properties'>IIPR</a> <font color='red'>-16%</font>. <a href='https://seekingalpha.com/symbol/AMPE' title='Ampio Pharmaceuticals, Inc.'>AMPE</a> <font color='red'>-16%</font>. <a href='https://seekingalpha.com/symbol/RENN' title='Renren Inc.'>RENN</a> <font color='red'>-15%</font>. <a href='https://seekingalpha.com/symbol/INSY' title='Insys Therapeutics, Inc.'>INSY</a> <font color='red'>-15%</font>. <a href='https://seekingalpha.com/symbol/REXX' title='Rex Energy Corporation'>REXX</a> <font color='red'>-15%</font>. <a href='https://seekingalpha.com/symbol/CATO' title='The Cato Corporation'>CATO</a> <font color='red'>-13%</font>. <a href='https://seekingalpha.com/symbol/BKE' title='The Buckle, Inc.'>BKE</a> <font color='red'>-13%</font>.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3321245\" data-linked=\"Midday Gainers / Losers\" data-tweet=\"$CNET $APOP $HTGM - Midday Gainers / Losers https://seekingalpha.com/news/3321245-midday-gainers-losers?source=tweet\" data-url=\"https://seekingalpha.com/news/3321245-midday-gainers-losers\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 12:40 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3321243\" data-ts=\"1515086840\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/AMZN\" target=\"_blank\">AMZN</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3321243-alexa-can-now-control-microwaves-ovens-amazon-invests-in-smart-oven-startup\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Alexa can now control microwaves, ovens; Amazon invests in smart oven startup</a></h4><ul><li>        Amazon&rsquo;s (NASDAQ:<a href='https://seekingalpha.com/symbol/AMZN' title='Amazon.com, Inc.'>AMZN</a>) Alexa will soon have the ability to control smart ovens and refrigerators. Support for other cooking devices will be added in the future.</li><li>               Amazon added cooking capabilities to the Smart Home Skill API so that manufacturers could integrate the capabilities into the smart kitchen products.&nbsp;&nbsp;</li><li>               Whirlpool has created an Alexa skill utilizing the cooking capabilities for its connected microwaves with a launch coming soon.&nbsp;</li><li>               GE Appliances, Kenmore, LG, and Samsung are working on integrating the capabilities into their smart ovens and appliances.&nbsp;</li><li>                  In a further push into the kitchen, Amazon&rsquo;s venture capital fund Alexa Fund invests in June Life, which makes the countertop smart oven June Oven. Terms of the investment not disclosed. June previously raised at least $29.5M in funding.    </li><li>               Amazon shares are&nbsp;<font color='green'>up 0.34%</font>.&nbsp;&nbsp;</li><li>Previously: <a href=\"https://seekingalpha.com/news/3321179-tech-giants-scurry-patch-chip-flaws-intel-minus-2_6-percent\" target=\"_blank\">Tech giants scurry to patch chip flaws; Intel -2.6%</a> (Jan. 4)</li><li>Previously: <a href=\"https://seekingalpha.com/news/3321218-oppenheimer-large-cap-revenue-etf-rwl-december-summary\" target=\"_blank\">Oppenheimer Large Cap Revenue ETF (NYSEARCA:<a href='https://seekingalpha.com/symbol/RWL-OLD' title='Oppenheimer Large Cap Revenue ETF'>RWL-OLD</a>) December Summary</a> (Jan. 4)</li></ul><div class=\"tiny-share-widget\" data-id=\"3321243\" data-linked=\"Alexa can now control microwaves, ovens; Amazon invests in smart oven startup\" data-tweet=\"$AMZN $AMZN $RWL-OLD - Alexa can now control microwaves, ovens; Amazon invests in smart oven startup https://seekingalpha.com/news/3321243-alexa-can-now-control-microwaves-ovens-amazon-invests-in-smart-oven-startup?source=tweet\" data-url=\"https://seekingalpha.com/news/3321243-alexa-can-now-control-microwaves-ovens-amazon-invests-in-smart-oven-startup\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 12:27 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>37&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3321238\" data-ts=\"1515085529\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/EBIX\" target=\"_blank\">EBIX</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3321238-ebixplus-2_9-on-fourth-remittance-related-acquisition\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Ebix +2.9% on fourth remittance-related acquisition</a></h4><ul><li>        Ebix (NASDAQ:<a href='https://seekingalpha.com/symbol/EBIX' title='Ebix Inc'>EBIX</a>) will <a href=\"https://seekingalpha.com/pr/17038218-ebix-signs-agreement-acquire-inward-international-remittance-business-transcorp-international\" target=\"_blank\">acquire</a> the Money Transfer Service Scheme business of Transcorp International Limited for $7.4M.</li><li>               Ebix expects the acquisition to become accretive immediately after closing. The deal was funded from the company&rsquo;s cash reserves.&nbsp;</li><li>                  The deal marks Ebix&rsquo;s fourth remittance-related acquisition. Transcorp&rsquo;s MTSS business controls the fifth largest share of the Indian remittance market.    </li><li>                  Ebix shares are&nbsp;<font color='green'>up 2.9%</font>.&nbsp; </li><li>Previously: <a href=\"https://seekingalpha.com/news/3320705-ebix-minus-2-percent-ending-vara-jv-bid\" target=\"_blank\">Ebix -2% on ending Vara JV bid</a> (Jan. 2)</li></ul><div class=\"tiny-share-widget\" data-id=\"3321238\" data-linked=\"Ebix +2.9% on fourth remittance-related acquisition\" data-tweet=\"$EBIX - Ebix +2.9% on fourth remittance-related acquisition https://seekingalpha.com/news/3321238-ebixplus-2_9-on-fourth-remittance-related-acquisition?source=tweet\" data-url=\"https://seekingalpha.com/news/3321238-ebixplus-2_9-on-fourth-remittance-related-acquisition\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 12:05 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>8&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3321235\" data-ts=\"1515085513\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/AEMD\" target=\"_blank\">AEMD</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3321235-aethlon-medical-up-33-ahead-of-60-minutes-report-of-cte-in-combat-veterans\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Aethlon Medical up 33% ahead of 60 Minutes report of CTE in combat veterans</a></h4><ul><li>Nano cap Aethlon Medical (<a href='https://seekingalpha.com/symbol/AEMD' title='Aethlon Medical, Inc.'>AEMD</a> <font color='green'>+33.3%</font>) spikes on modestly higher volume in apparent response to an upcoming <a href=\"https://www.cbsnews.com/news/combat-veterans-suffering-from-same-brain-disease-as-concussion-victims/\" target=\"_blank\">segment </a>of 60 Minutes (Sunday, Jan. 7) about the same degenerative brain disease in soldiers returning from combat as former football players.</li><li>The disorder, chronic traumatic encephalopathy &#40;CTE&#41;, was found in 110 of 111 brains of deceased NFL players in a study conducted at Boston University.</li><li>It appears that soldiers endure similar brain trauma from bomb blasts in combat.</li><li>The company is the majority stockholder in <a href=\"https://www.aethlonmedical.com/about/exosome-sciences-inc\" target=\"_blank\">Exosome Sciences</a> which discovered a biomarker called TauSome that can potentially be used to detect CTE in living persons.</li></ul><div class=\"tiny-share-widget\" data-id=\"3321235\" data-linked=\"Aethlon Medical up 33% ahead of 60 Minutes report of CTE in combat veterans\" data-tweet=\"$AEMD - Aethlon Medical up 33% ahead of 60 Minutes report of CTE in combat veterans https://seekingalpha.com/news/3321235-aethlon-medical-up-33-ahead-of-60-minutes-report-of-cte-in-combat-veterans?source=tweet\" data-url=\"https://seekingalpha.com/news/3321235-aethlon-medical-up-33-ahead-of-60-minutes-report-of-cte-in-combat-veterans\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 12:05 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>6&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3321236\" data-ts=\"1515085362\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3321236-consumer-top-gainers-losers-of-12-00-pm\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Consumer - Top Gainers / Losers as of 12:00 pm</a></h4><ul>     <li><b>Gainers:</b> <a href='https://seekingalpha.com/symbol/SGOC' title='SGOCO Techn'>SGOC</a> <font color='green'>+15%</font>. <a href='https://seekingalpha.com/symbol/FTFT' title='Future Fintech Group Inc'>FTFT</a> <font color='green'>+13%</font>. <a href='https://seekingalpha.com/symbol/ENR' title='Energizer Holdings, Inc.'>ENR</a> <font color='green'>+7%</font>. <a href='https://seekingalpha.com/symbol/ZX' title='China Zenix Auto International'>ZX</a> <font color='green'>+7%</font>. <a href='https://seekingalpha.com/symbol/EFOI' title='Energy Focus, Inc.'>EFOI</a> <font color='green'>+6%</font>.</li><li><b>Losers:</b> <a href='https://seekingalpha.com/symbol/WATT' title='Energous Corp.'>WATT</a> <font color='red'>-7%</font>. <a href='https://seekingalpha.com/symbol/ADOM' title='ADOMANI, Inc.'>ADOM</a> <font color='red'>-5%</font>.</li></ul><div class=\"tiny-share-widget\" data-id=\"3321236\" data-linked=\"Consumer - Top Gainers / Losers as of 12:00 pm\" data-tweet=\"$SGOC $FTFT $ENR - Consumer - Top Gainers / Losers as of 12:00 pm https://seekingalpha.com/news/3321236-consumer-top-gainers-losers-of-12-00-pm?source=tweet\" data-url=\"https://seekingalpha.com/news/3321236-consumer-top-gainers-losers-of-12-00-pm\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 12:02 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>3&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3321240\" data-ts=\"1515085262\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/CASM\" target=\"_blank\">CASM</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3321240-casmed-reports-preliminary-q4-revenue-sharesplus-14\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">CASMED reports preliminary Q4 revenue; shares +14%</a></h4><ul>     <li>CAS Medical Systems (NASDAQ:<a href='https://seekingalpha.com/symbol/CASM' title='CAS Medical Systems, Inc.'>CASM</a>) expects net sales from continuing operations for the Q417 to be ~$5.1M (+11% Y/Y) vs. a consensus of $4.53M.</li>     <li>Net sales for the FY17 are expected to ~$18.7M (flat Y/Y) vs. a consensus of $18.46M.</li>     <li>The Company&rsquo;s year-end cash balance plus cash available under its line of credit was ~$7.4M.</li>     <li><strong>Expected FORE-SIGHT&reg; highlights for the Q417 vs. Q416.</strong></li>     <li>U.S. FORE-SIGHT cerebral oximetry sales increased 18% (y/y) to ~$4.3M, driven by strong monitor sales, and an 8% increase in U.S. FORE-SIGHT sensor sales.</li>     <li>A net 110 FORE-SIGHT cerebral oximeters were shipped to new and existing customers worldwide, driven by a record net 80 monitors shipped in the U.S.</li>     <li>The installed base of U.S. monitors grew to 1,318 (+17.67% Y/Y) as of Dec. 31, 2017.</li>     <li>Total FORE-SIGHT sales increased 12% to ~$5.0M.</li>     <li><a href=\"https://seekingalpha.com/pr/17038125-casmed-reports-preliminary-net-sales-2017-fourth-quarter\" target=\"_blank\">Press Release</a></li> </ul><div class=\"tiny-share-widget\" data-id=\"3321240\" data-linked=\"CASMED reports preliminary Q4 revenue; shares +14%\" data-tweet=\"$CASM - CASMED reports preliminary Q4 revenue; shares +14% https://seekingalpha.com/news/3321240-casmed-reports-preliminary-q4-revenue-sharesplus-14?source=tweet\" data-url=\"https://seekingalpha.com/news/3321240-casmed-reports-preliminary-q4-revenue-sharesplus-14\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 12:01 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3321231\" data-ts=\"1515083983\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/MSFT\" target=\"_blank\">MSFT</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3321231-coming-soon-microsofts-319-cortana-powered-thermostat\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Coming soon: Microsoft&#39;s $319 Cortana-powered thermostat</a></h4><ul><li>        Microsoft&rsquo;s (NASDAQ:<a href='https://seekingalpha.com/symbol/MSFT' title='Microsoft Corporation'>MSFT</a>) translucent, Cortana-powered smart thermostat GLAS will be available for preorders soon. &nbsp;&nbsp;</li><li>        The tech giant partnered with Johnson Controls on the thermostat, which includes temperature controls, weather forecasts, and skills accessible through the mobile app, a browser, or voice controls.</li><li>               The preorder period starts in March with a price of $319, which is higher than similar products from Google&rsquo;s Nest and Amazon Alexa-enabled thermostats like the Ecobee. &nbsp;&nbsp;&nbsp;</li><li>               Microsoft shares are&nbsp;<font color='green'>up 1.4%</font>.&nbsp;&nbsp;&nbsp;&nbsp;</li><li>Previously: <a href=\"https://seekingalpha.com/news/3321138-oppenheimer-esg-revenue-etf-esgl-december-summary\" target=\"_blank\">Oppenheimer ESG Revenue ETF (NYSEARCA:<a href='https://seekingalpha.com/symbol/ESGL' title='Oppenheimer ESG Revenue ETF'>ESGL</a>) December Summary</a> (Jan. 4)</li></ul><div class=\"tiny-share-widget\" data-id=\"3321231\" data-linked=\"Coming soon: Microsoft&#39;s $319 Cortana-powered thermostat\" data-tweet=\"$MSFT $MSFT $ESGL - Coming soon: Microsoft&#39;s $319 Cortana-powered thermostat https://seekingalpha.com/news/3321231-coming-soon-microsofts-319-cortana-powered-thermostat?source=tweet\" data-url=\"https://seekingalpha.com/news/3321231-coming-soon-microsofts-319-cortana-powered-thermostat\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:39 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>18&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3321220\" data-ts=\"1515082410\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/DXCM\" target=\"_blank\">DXCM</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3321220-dexcom-down-10-on-medicare-coverage-for-abbotts-freestyle-libre-cgm\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">DexCom down 10% on Medicare coverage for Abbott&#39;s FreeStyle Libre CGM</a></h4><ul><li>DexCom (<a href='https://seekingalpha.com/symbol/DXCM' title='DexCom, Inc.'>DXCM</a> <font color='red'>-10.3%</font>) is under pressure on 50% higher volume in apparent response to Abbott's (<a href='https://seekingalpha.com/symbol/ABT' title='Abbott Laboratories'>ABT</a> <font color='green'>+0.5%</font>) <a href=\"https://seekingalpha.com/pr/17038011-abbotts-revolutionary-continuous-glucose-monitoring-system-freestyle-libre-now-available\" target=\"_blank\">announcement </a>that its continuous glucose monitoring &#40;CGM&#41; system, FreeStyle Libre, now has Medicare coverage.</li><li>Abbott says the device is calibrated at the factory so no user calibration is necessary and there is no need for routine fingersticks. DexCom's <a href=\"https://www.dexcom.com/get-started-cgm?utm_source=adwords&amp;utm_campaign=b&amp;sfc=70133000001LlpgAAC&amp;gclid=Cj0KCQiAvrfSBRC2ARIsAFumcm-Z998P2s4BoIJyDA0RFjjipG1cIPxoGy38izPM7_fFt5yXQF7YbqoaAklQEALw_wcB\" target=\"_blank\">G5 </a>requires both.</li></ul><div class=\"tiny-share-widget\" data-id=\"3321220\" data-linked=\"DexCom down 10% on Medicare coverage for Abbott&#39;s FreeStyle Libre CGM\" data-tweet=\"$DXCM $DXCM $ABT - DexCom down 10% on Medicare coverage for Abbott&#39;s FreeStyle Libre CGM https://seekingalpha.com/news/3321220-dexcom-down-10-on-medicare-coverage-for-abbotts-freestyle-libre-cgm?source=tweet\" data-url=\"https://seekingalpha.com/news/3321220-dexcom-down-10-on-medicare-coverage-for-abbotts-freestyle-libre-cgm\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:13 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>15&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3321221\" data-ts=\"1515082380\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/DATA\" target=\"_blank\">DATA</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3321221-tableau-softwareminus-2_3-on-analyst-downgrade\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Tableau Software -2.3% on analyst downgrade</a></h4><ul><li>        KeyBanc <a href=\"https://markets.ft.com/data/equities/tearsheet/forecasts?s=DATA:NYQ\" target=\"_blank\">downgrades</a> Tableau Software (NYSE:<a href='https://seekingalpha.com/symbol/DATA' title='Tableau Software'>DATA</a>) from Overweight to Sector Weight.</li><li>               Latest analyst recommendations: 7 Buy, 8 Outperform, 16 Hold, 2 Underperform, and 1 Sell.&nbsp;</li><li>                  Median price target: $77.   </li><li>                  Tableau shares are&nbsp;<font color='red'>down 2.3%</font>&nbsp;to $70.07. &nbsp;   &nbsp;</li></ul><div class=\"tiny-share-widget\" data-id=\"3321221\" data-linked=\"Tableau Software -2.3% on analyst downgrade\" data-tweet=\"$DATA - Tableau Software -2.3% on analyst downgrade https://seekingalpha.com/news/3321221-tableau-softwareminus-2_3-on-analyst-downgrade?source=tweet\" data-url=\"https://seekingalpha.com/news/3321221-tableau-softwareminus-2_3-on-analyst-downgrade\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:13 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3321213\" data-ts=\"1515081805\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/ONCE\" target=\"_blank\">ONCE</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3321213-sparks-pricing-for-luxturna-fails-to-ignite-buying-shares-down-6\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Spark&#39;s pricing for Luxturna fails to ignite buying, shares down 6%</a></h4><ul><li>Spark Therapeutics (<a href='https://seekingalpha.com/symbol/ONCE' title='Spark Therapeutics'>ONCE</a> <font color='red'>-6.3%</font>) is on the outside looking in on the market's up move, albeit on average volume.</li><li>The company's price of $425K per eye for the gene therapy was well-received.</li><li>Four sell-side shops that recently updated coverage. All rate the stock a Buy with price targets ranging from $66 to $113. Raymond James lowered its target to $66 from $75, however.</li><li>Previously: <a href=\"https://seekingalpha.com/news/3320874-spark-prices-gene-therapy-luxturna-850k\" target=\"_blank\">Spark prices gene therapy Luxturna at $850K</a> (Jan. 3)</li></ul><div class=\"tiny-share-widget\" data-id=\"3321213\" data-linked=\"Spark&#39;s pricing for Luxturna fails to ignite buying, shares down 6%\" data-tweet=\"$ONCE - Spark&#39;s pricing for Luxturna fails to ignite buying, shares down 6% https://seekingalpha.com/news/3321213-sparks-pricing-for-luxturna-fails-to-ignite-buying-shares-down-6?source=tweet\" data-url=\"https://seekingalpha.com/news/3321213-sparks-pricing-for-luxturna-fails-to-ignite-buying-shares-down-6\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:03 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>10&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3321216\" data-ts=\"1515081674\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/S\" target=\"_blank\">S</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3321216-wells-fargo-sprint-cfo-change-feeds-spending-narrative\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Wells Fargo: Sprint CFO change feeds spending narrative</a></h4><ul>   <li>Sprint (NYSE:<a href='https://seekingalpha.com/symbol/S' title='Sprint Corporation'>S</a>) is <font color='red'>off 4.4%</font> since announcing a <a href=\"https://seekingalpha.com/news/3321175-altices-combes-replaces-robbiati-sprints-cfo\" target=\"_blank\">changeover in its chief financial officer</a> this morning, with former Altice CEO Michel Combes taking over for Tarek Robbiati and signaling a \"new phase of transformation.\"</li>    <li>Wells Fargo's Jennifer Fritzsche <a href=\"https://www.barrons.com/articles/sprint-drops-5-cfo-switch-feeds-narrative-of-spending-says-wells-1515080226\" target=\"_blank\">isn't surprised by the downturn</a> on the news: \"Unfortunately, we believe this feeds the narrative of concern that S needs to spend on network and continue to aggressively cut costs,\" she writes.</li>    <li>Robbiati did as asked in lowering cost of capital, but Combes' expertise (Sprint calls hime a \"turnaround strategist\") will be useful at this point in Sprint's evolution, she says. Key questions will be be \"What is Combes' view on financing (and funding of S's capx initiatives) and continued ability to cut costs.\"</li> </ul><div class=\"tiny-share-widget\" data-id=\"3321216\" data-linked=\"Wells Fargo: Sprint CFO change feeds spending narrative\" data-tweet=\"$S - Wells Fargo: Sprint CFO change feeds spending narrative https://seekingalpha.com/news/3321216-wells-fargo-sprint-cfo-change-feeds-spending-narrative?source=tweet\" data-url=\"https://seekingalpha.com/news/3321216-wells-fargo-sprint-cfo-change-feeds-spending-narrative\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:01 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>67&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3321192\" data-ts=\"1515081647\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3321192-healthcare-top-5-gainers-losers-of-11-00\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Healthcare - Top 5 Gainers / Losers as of 11:00 am</a></h4><ul>     <li><b>Gainers:</b> <a href='https://seekingalpha.com/symbol/APOP' title='Cellect Biotechnology Ltd.'>APOP</a> <font color='green'>+54%</font>. <a href='https://seekingalpha.com/symbol/CCXI' title='ChemoCentryx'>CCXI</a> <font color='green'>+38%</font>. <a href='https://seekingalpha.com/symbol/AHPI' title='Allied Healthcare Products, Inc.'>AHPI</a> <font color='green'>+16%</font>. <a href='https://seekingalpha.com/symbol/BOLD' title='Audentes Therapeutics'>BOLD</a> <font color='green'>+14%</font>. <a href='https://seekingalpha.com/symbol/VNRX' title='VolitionRX Ltd'>VNRX</a> <font color='green'>+13%</font>.</li><li><b>Losers:</b> <a href='https://seekingalpha.com/symbol/AQB' title='AquaBounty Technologies, Inc.'>AQB</a> <font color='red'>-19%</font>. <a href='https://seekingalpha.com/symbol/INSY' title='Insys Therapeutics, Inc.'>INSY</a> <font color='red'>-17%</font>. <a href='https://seekingalpha.com/symbol/DXCM' title='DexCom, Inc.'>DXCM</a> <font color='red'>-9%</font>. <a href='https://seekingalpha.com/symbol/DRIO' title='DarioHealth Corp.'>DRIO</a> <font color='red'>-8%</font>. <a href='https://seekingalpha.com/symbol/ONCE' title='Spark Therapeutics'>ONCE</a> <font color='red'>-8%</font>.</li></ul><div class=\"tiny-share-widget\" data-id=\"3321192\" data-linked=\"Healthcare - Top 5 Gainers / Losers as of 11:00 am\" data-tweet=\"$APOP $CCXI $AHPI - Healthcare - Top 5 Gainers / Losers as of 11:00 am https://seekingalpha.com/news/3321192-healthcare-top-5-gainers-losers-of-11-00?source=tweet\" data-url=\"https://seekingalpha.com/news/3321192-healthcare-top-5-gainers-losers-of-11-00\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:00 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>2&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3321215\" data-ts=\"1515081626\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3321215-eia-petroleum-inventories\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">EIA Petroleum Inventories</a></h4><ul>     <li><a href=\"http://ir.eia.gov/wpsr/wpsrsummary.pdf\" target=\"_blank\">EIA Petroleum Inventories</a>: Crude <strong>-7.4M </strong>barrels vs. -5.1M consensus, -4.6M last week.</li><li>Gasoline&nbsp;<strong>+4.8M</strong>&nbsp;barrels vs. +2.2M consensus, +0.6M last week.</li><li>Distillates&nbsp;<strong>+8.9M</strong>&nbsp;barrels vs. +0.5M consensus, +1.1M last week.</li>     <li>Futures&nbsp;<font color='green'>+0.28%&nbsp;</font>to $61.78.</li>     <li>ETFs:<a href='https://seekingalpha.com/symbol/USO' title='The United States Oil ETF, LP'>USO</a>, <a href='https://seekingalpha.com/symbol/OIL' title='iPath S&P Crude Oil Total Return Index ETN'>OIL</a>, <a href='https://seekingalpha.com/symbol/UCO' title='ProShares Ultra Bloomberg Crude Oil ETF'>UCO</a>, <a href='https://seekingalpha.com/symbol/SCO' title='ProShares UltraShort Bloomberg Crude Oil ETF'>SCO</a>, <a href='https://seekingalpha.com/symbol/BNO' title='The United States Brent Oil ETF, LP'>BNO</a>, <a href='https://seekingalpha.com/symbol/DTO' title='DB Crude Oil Double Short ETN'>DTO</a>, <a href='https://seekingalpha.com/symbol/DBO' title='PowerShares DB Oil ETF'>DBO</a>, <a href='https://seekingalpha.com/symbol/USL' title='The United States 12 Month Oil ETF, LP'>USL</a>, <a href='https://seekingalpha.com/symbol/DNO' title='The United States Short Oil ETF, LP'>DNO</a>, <a href='https://seekingalpha.com/symbol/SZO' title='DB Crude Oil Short ETN'>SZO</a>, <a href='https://seekingalpha.com/symbol/OLO' title='DB Crude Oil Long ETN'>OLO</a>, <a href='https://seekingalpha.com/symbol/OLEM' title='iPath Pure Beta Crude Oil ETN'>OLEM</a></li> </ul><div class=\"tiny-share-widget\" data-id=\"3321215\" data-linked=\"EIA Petroleum Inventories\" data-tweet=\"$USO $OIL $UCO - EIA Petroleum Inventories https://seekingalpha.com/news/3321215-eia-petroleum-inventories?source=tweet\" data-url=\"https://seekingalpha.com/news/3321215-eia-petroleum-inventories\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:00 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>38&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3321209\" data-ts=\"1515080929\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/LB\" target=\"_blank\">LB</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3321209-jittery-trading-on-apparel-store-stocks\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Jittery trading on apparel store stocks</a></h4><ul> <li>Apparel store stocks are lower as a whole after disappointing updates from L Brands (<a href='https://seekingalpha.com/symbol/LB' title='L Brands, Inc.'>LB</a> <font color='red'>-15.1%</font>), Cato (<a href='https://seekingalpha.com/symbol/CATO' title='The Cato Corporation'>CATO</a> <font color='red'>-13.7%</font>) and Buckle (<a href='https://seekingalpha.com/symbol/BKE' title='The Buckle, Inc.'>BKE</a> <font color='red'>-12.1%</font>) offset a sizzler from Zumiez (<a href='https://seekingalpha.com/symbol/ZUMZ' title='Zumiez Inc.'>ZUMZ</a> <font color='green'>+13.2%</font>).</li> <li>The sector is sensitive with the ICR Conference on the calendar for next week when many retailers are expected to post guidance updates.</li> <li>Decliners include Chico's FAS (<a href='https://seekingalpha.com/symbol/CHS' title='Chico&#39;s FAS, Inc.'>CHS</a> <font color='red'>-9.3%</font>), Express (<a href='https://seekingalpha.com/symbol/EXPR' title='Express, Inc.'>EXPR</a> <font color='red'>-7.5%</font>), Abercrombie &amp; Fitch (<a href='https://seekingalpha.com/symbol/ANF' title='Abercrombie & Fitch'>ANF</a> <font color='red'>-7%</font>), Genesco (<a href='https://seekingalpha.com/symbol/GCO' title='Genesco Inc.'>GCO</a> <font color='red'>-6.7%</font>), Stage Stores (<a href='https://seekingalpha.com/symbol/SSI' title='Stage Stores, Inc.'>SSI</a> <font color='red'>-3.6%</font>), Guess (<a href='https://seekingalpha.com/symbol/GES' title='Guess? Inc.'>GES</a> <font color='red'>-4.7%</font>), Urban Outfitters (<a href='https://seekingalpha.com/symbol/URBN' title='Urban Outfitters, Inc.'>URBN</a> <font color='red'>-4.7%</font>), Destination XL Grouyp (<a href='https://seekingalpha.com/symbol/DXLG' title='Destination XL Group, Inc.'>DXLG</a> <font color='red'>-4.4%</font>), Citi Trends (<a href='https://seekingalpha.com/symbol/CTRN' title='Citi Trends, Inc.'>CTRN</a> <font color='red'>-3.2%</font>), Gap (<a href='https://seekingalpha.com/symbol/GPS' title='The Gap, Inc.'>GPS</a> <font color='red'>-3.5%</font>) and Tilly's (<a href='https://seekingalpha.com/symbol/TLYS' title='Tilly&#39;s, Inc.'>TLYS</a> <font color='red'>-3.5%</font>).</li> </ul><div class=\"tiny-share-widget\" data-id=\"3321209\" data-linked=\"Jittery trading on apparel store stocks\" data-tweet=\"$LB $LB $CATO - Jittery trading on apparel store stocks https://seekingalpha.com/news/3321209-jittery-trading-on-apparel-store-stocks?source=tweet\" data-url=\"https://seekingalpha.com/news/3321209-jittery-trading-on-apparel-store-stocks\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:48 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>7&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3321206\" data-ts=\"1515080366\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/CNET\" target=\"_blank\">CNET</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3321206-chinanet-onlineplus-145-latest-to-ring-bell-on-blockchain-pivot\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">ChinaNet Online +145%, latest to ring bell on blockchain pivot</a></h4><ul>   <li>ChinaNet Online Holdings (NASDAQ:<a href='https://seekingalpha.com/symbol/CNET' title='ChinaNet Online Holdings, Inc.'>CNET</a>) has <font color='green'>vaulted 145%</font>, more than doubling market cap to $35.4M, after announcing <a href=\"https://seekingalpha.com/pr/17037730-chinanet-online-holdings-announces-strategic-partnership-jingtum-technology\" target=\"_blank\">its own blockchain move</a> -- a strategic partnership with Wuxi Jingtum Network Technology.</li>    <li>The two companies will exchange work in order to jointly develop blockchain applications, they say.</li>    <li>Jingtum says its system is a \"decentralized and ecologically interactive Internet trading network based on blockchain technology.\"</li>    <li>The two will work to build a platform for \"business opportunities and transactions.\"</li> </ul><div class=\"tiny-share-widget\" data-id=\"3321206\" data-linked=\"ChinaNet Online +145%, latest to ring bell on blockchain pivot\" data-tweet=\"$CNET - ChinaNet Online +145%, latest to ring bell on blockchain pivot https://seekingalpha.com/news/3321206-chinanet-onlineplus-145-latest-to-ring-bell-on-blockchain-pivot?source=tweet\" data-url=\"https://seekingalpha.com/news/3321206-chinanet-onlineplus-145-latest-to-ring-bell-on-blockchain-pivot\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:39 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3321202\" data-ts=\"1515079673\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/COST\" target=\"_blank\">COST</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3321202-costco-in-reverse-despite-blazing-sales-report\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Costco in reverse despite blazing sales report</a></h4><ul>     <li>It's hard to see what Costco (NASDAQ:<a href='https://seekingalpha.com/symbol/COST' title='Costco Wholesale Corporation'>COST</a>) did wrong in December after the retailer walloped estimates with a same-store sales increase of 11.5% to sail past the consensus estimate of 8.1%.</li>     <li>The impressive monthly sales report was underpinned by a 6.4% rise in U.S. traffic and 33% jump in digital sales. Those two marks outpace the bulk of the retail sector.</li>     <li>Gordon Haskett analyst <a href=\"https://www.thestreet.com/story/14436958/1/amazon-is-clearly-having-almost-no-impact-on-costco.html\" target=\"_blank\">Chuck Grom</a> says the monthly report from Costco is a \"testament to the model, which is generating strong comps from both new and mature units.\"</li>     <li>Shares of Costco are <font color='red'>down 1.08%</font> on the day as the retailer's string of positive sales reports (August to December: +7%, +9%, +8%, +11%, +12%) brings about a bit of complacency with investors.</li>     <li>Previously: <a href=\"https://seekingalpha.com/news/3321078-costco-reports-strong-comp-sales-ex-gas-f-x-december\" target=\"_blank\">Costco reports strong comp sales (ex-gas and F/X) in December</a> (Jan. 4)</li> </ul><div class=\"tiny-share-widget\" data-id=\"3321202\" data-linked=\"Costco in reverse despite blazing sales report\" data-tweet=\"$COST - Costco in reverse despite blazing sales report https://seekingalpha.com/news/3321202-costco-in-reverse-despite-blazing-sales-report?source=tweet\" data-url=\"https://seekingalpha.com/news/3321202-costco-in-reverse-despite-blazing-sales-report\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:27 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>17&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3321201\" data-ts=\"1515079308\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/BBU\" target=\"_blank\">BBU</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3321201-brookfield-business-partners-buys-bankrupt-toshiba-unit-for-4_6b\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Brookfield Business Partners buys bankrupt Toshiba unit for $4.6B</a></h4><ul><li>        Brookfield Business Partners (NYSE:<a href='https://seekingalpha.com/symbol/BBU' title='Brookfield Business Partners L.P.'>BBU</a>) <a href=\"http://www.nasdaq.com/article/brookfield-business-partners-to-buy-toshiba-westinghouse-electric-for-46-bln-20180104-00598\" target=\"_blank\">agrees to purchase</a> Toshiba&rsquo;s (<a href='https://seekingalpha.com/symbol/TOSBF' title='Toshiba Corp.'>OTCPK:TOSBF</a>, <a href='https://seekingalpha.com/symbol/TOSYY' title='Toshiba Corp. ADR'>OTCPK:TOSYY</a>) bankrupt nuclear power company Westinghouse Electric.</li><li>                  Deal price around $4.6B funded with approximately $1B of equity, 3B of long-term debt financing, and finished off with the assumption of certain operating obligations.    </li><li>               Brookfield Business Partners will fund approximately 50% of equity on closing using existing liquidity. &nbsp;&nbsp;</li><li>               Brookfield shares are&nbsp;<font color='green'>up 3%</font>.&nbsp;&nbsp;&nbsp;&nbsp;</li><li>Previously: <a href=\"https://seekingalpha.com/news/3320207-toshiba-hit-class-action-suit-cancelled-nuclear-project\" target=\"_blank\">Toshiba hit with class action suit over cancelled nuclear project</a> (Dec. 27, 2017)</li></ul><div class=\"tiny-share-widget\" data-id=\"3321201\" data-linked=\"Brookfield Business Partners buys bankrupt Toshiba unit for $4.6B\" data-tweet=\"$BBU $BBU $TOSBF - Brookfield Business Partners buys bankrupt Toshiba unit for $4.6B https://seekingalpha.com/news/3321201-brookfield-business-partners-buys-bankrupt-toshiba-unit-for-4_6b?source=tweet\" data-url=\"https://seekingalpha.com/news/3321201-brookfield-business-partners-buys-bankrupt-toshiba-unit-for-4_6b\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:21 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>16&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3321186\" data-ts=\"1515076649\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/LBUY\" target=\"_blank\">LBUY</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3321186-leafbuyer-technologies-moves-to-otcqb\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Leafbuyer Technologies moves to the OTCQB</a></h4><ul> <li>Cannabis tech player Leafbuyer Technologies (<a href='https://seekingalpha.com/symbol/LBUY' title='Leafbuyer Technologies, Inc.'>OTCQB:LBUY</a>) announces that it has&nbsp;been approved       and upgraded from the Pink Open Market to the OTCQB Venture Market.</li>     <li>\"In 2018 our strategic plan will include advancements in our technology       as well as the expansion into other legal markets including Canada,\"       says Leafbuyer CEO&nbsp;Kurt Rossner.&nbsp;\"This significant       upgrade will increase the trading liquidity of our stock, expand our       stockholder base, and raise our profile in the investment community,\" he adds.</li><li>Source: <a href=\"https://seekingalpha.com/pr/17038106-leafbuyer-technologies-inc-approved-trading-otcqb-venture-market\" target=\"_blank\">Press Release</a></li></ul><div class=\"tiny-share-widget\" data-id=\"3321186\" data-linked=\"Leafbuyer Technologies moves to the OTCQB\" data-tweet=\"$LBUY - Leafbuyer Technologies moves to the OTCQB https://seekingalpha.com/news/3321186-leafbuyer-technologies-moves-to-otcqb?source=tweet\" data-url=\"https://seekingalpha.com/news/3321186-leafbuyer-technologies-moves-to-otcqb\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:37 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3321185\" data-ts=\"1515076629\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/RSYS\" target=\"_blank\">RSYS</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3321185-radisysplus-2_9-on-preliminary-q4-results\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Radisys +2.9% on preliminary Q4 results</a></h4><ul><li>        Radisys (NASDAQ:<a href='https://seekingalpha.com/symbol/RSYS' title='RadiSys Corporation'>RSYS</a>) <a href=\"https://seekingalpha.com/pr/17037779-radisys-closes-17-million-senior-notes-financing-support-software-systems-business-strategy\" target=\"_blank\">releases</a> preliminary Q4 results with revenue of $32M (previous midpoint: $31M.)</li><li>        The company expects to record a one-time inventory charge of up to $11M in the quarter.</li><li>                  Radisys expects to recognize a restructuring charge of approximately $7M through Q2, which is primarily due to employee severance and non-cash asset write-downs.    </li><li>               The company also announces closing a $17M financing round and entering a new $20M asset-backed line of credit. &nbsp;&nbsp;</li><li>               Radisys shares are&nbsp;<font color='green'>up 2.9%</font>.&nbsp;&nbsp;&nbsp;&nbsp;</li></ul><div class=\"tiny-share-widget\" data-id=\"3321185\" data-linked=\"Radisys +2.9% on preliminary Q4 results\" data-tweet=\"$RSYS - Radisys +2.9% on preliminary Q4 results https://seekingalpha.com/news/3321185-radisysplus-2_9-on-preliminary-q4-results?source=tweet\" data-url=\"https://seekingalpha.com/news/3321185-radisysplus-2_9-on-preliminary-q4-results\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:37 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3321180\" data-ts=\"1515076141\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/TEUM\" target=\"_blank\">TEUM</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3321180-pareteumplus-4_7-on-deal-win-social-media-app-provider\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Pareteum +4.7% on deal win with social-media app provider</a></h4><ul>   <li>Pareteum (NYSEMKT:<a href='https://seekingalpha.com/symbol/TEUM' title='Pareteum Corporation'>TEUM</a>) is <font color='green'>up 4.7%</font> premarket after it says it's <a href=\"https://seekingalpha.com/pr/17037769-social-media-provider-enables-smartphone-services-pareteums-global-cloud\" target=\"_blank\">won a three-year agreement</a> to offer customer-branded services to a UK-based social media app service provider.</li>    <li>The deal adds $1M in incremental revenue to its 36-month revenue backlog, which it noted yesterday had hit a record $147M.</li>    <li>The customer has a long history of providing interactive voice response, telecoms, mobile and credit card services, Pareteum says.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3321180\" data-linked=\"Pareteum +4.7% on deal win with social-media app provider\" data-tweet=\"$TEUM - Pareteum +4.7% on deal win with social-media app provider https://seekingalpha.com/news/3321180-pareteumplus-4_7-on-deal-win-social-media-app-provider?source=tweet\" data-url=\"https://seekingalpha.com/news/3321180-pareteumplus-4_7-on-deal-win-social-media-app-provider\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:29 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>4&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3321179\" data-ts=\"1515076028\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/INTC\" target=\"_blank\">INTC</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3321179-tech-giants-scurry-to-patch-chip-flaws-intelminus-2_6\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Tech giants scurry to patch chip flaws; Intel -2.6%</a></h4><ul><li>        The Intel (NASDAQ:<a href='https://seekingalpha.com/symbol/INTC' title='Intel Corporation'>INTC</a>) chip flaw reported yesterday traces back to two bugs and involves several tech giants.</li><li>               The bugs, nicknamed Meltdown and Spectre, make working memory data in shared servers or individual devices vulnerable to attack. But a hacker would first need to run malicious software on the CPU of the targeted machine.&nbsp;</li><li>               Google (<a href='https://seekingalpha.com/symbol/GOOG' title='Alphabet, Inc. Cl C'>GOOG</a>, <a href='https://seekingalpha.com/symbol/GOOGL' title='Alphabet, Inc. Cl A'>GOOGL</a>) says Android OS users who have installed the latest security fixes don&rsquo;t need to take further action. Chrome browser users might need to take action to fix the flaws. Cloud customers must implement the patch made available.</li><li>               Amazon (NASDAQ:<a href='https://seekingalpha.com/symbol/AMZN' title='Amazon.com, Inc.'>AMZN</a>) told data center customers patching is underway.&nbsp;</li><li>               The Meltdown bug is easier to patch. The Spectre flaw affects chips from Intel, AMD, and SoftBank&rsquo;s ARM. AMD fixed one of the vulnerabilities with software patches and says &ldquo;there is a near zero risk&rdquo; the company&rsquo;s chips could suffer attacks under the other vulnerabilities.&nbsp;</li><li>               Intel GM of data center engineering Stephen Smith said the flaws aren&rsquo;t &ldquo;the result of product erratum. The processors are really operating as they should operate, as they were designed to operate and validated to operate.&nbsp;</li><li>               Intel shares are&nbsp;<font color='red'>down 2.6%</font>&nbsp;premarket.&nbsp;</li><li>               AMD shares are&nbsp;<font color='green'>up 4.3%&nbsp;</font>premarket.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</li><li>Previously: <a href=\"https://seekingalpha.com/news/3321016-intel-responds-security-flaw-report-intc-trims-losses-amd-cuts-gains-updated\" target=\"_blank\">Intel responds to security flaw report; INTC trims losses, AMD cuts gains (updated)</a> (Jan. 3)</li><li>Previously: <a href=\"https://seekingalpha.com/news/3321030-arm-holdings-working-intel-amd-processor-exploit-issue\" target=\"_blank\">ARM Holdings working with Intel, AMD on processor exploit issue</a> (Jan. 3)</li><li>Previously: <a href=\"https://seekingalpha.com/news/3321048-amd-processor-exploit-near-zero-risk-chips\" target=\"_blank\">AMD: Processor exploit is 'near-zero' risk to its chips</a> (Jan. 3)</li><li>Previously: <a href=\"https://seekingalpha.com/news/3321084-intel-ceo-share-sale-spotlight\" target=\"_blank\">Intel CEO share sale under the spotlight</a> (Jan. 4)</li></ul><div class=\"tiny-share-widget\" data-id=\"3321179\" data-linked=\"Tech giants scurry to patch chip flaws; Intel -2.6%\" data-tweet=\"$INTC $INTC $GOOG - Tech giants scurry to patch chip flaws; Intel -2.6% https://seekingalpha.com/news/3321179-tech-giants-scurry-to-patch-chip-flaws-intelminus-2_6?source=tweet\" data-url=\"https://seekingalpha.com/news/3321179-tech-giants-scurry-to-patch-chip-flaws-intelminus-2_6\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:27 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>42&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3321177\" data-ts=\"1515075667\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/APOP\" target=\"_blank\">APOP</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3321177-cellect-bios-apograft-stem-cells-completely-accepted-first-blood-cancer-patients-in-phase-1-2\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Cellect Bio&#39;s ApoGraft stem cells completely accepted by first blood cancer patients in Phase 1/2 study; shares up 86% premarket</a></h4><ul><li>Thinly traded nano cap Cellect Biotechnology (NASDAQ:<a href='https://seekingalpha.com/symbol/APOP' title='Cellect Biotechnology Ltd.'>APOP</a>) is up&nbsp;<font color='green'>86%</font>&nbsp;premarket on robust volume in response to <a href=\"https://seekingalpha.com/pr/17037739-cellect-announces-breakthrough-clinical-results\" target=\"_blank\">encouraging results</a> in a Phase 1/2 clinical trial assessing ApoGraft-processed donor-derived peripheral blood cells transplanted into blood cancer patients.</li><li>The primary endpoint is safety, specifically the frequency and severity of adverse events within 180 days of transplantation.</li><li>After one month of follow-up, the first three patients showed complete acceptance of the stem cell transplant with no treatment-related adverse events observed.</li><li>The most prevalent adverse event related to stem cell transplantation is graft-versus-host disease (GvHD) which occurs in 25 - 50% of recipients. ApoGraft is a stem cell selection process designed to reduce the risk of GvHD.</li></ul><div class=\"tiny-share-widget\" data-id=\"3321177\" data-linked=\"Cellect Bio&#39;s ApoGraft stem cells completely accepted by first blood cancer patients in Phase 1/2 study; shares up 86% premarket\" data-tweet=\"$APOP - Cellect Bio&#39;s ApoGraft stem cells completely accepted by first blood cancer patients in Phase 1/2 study; shares up 86% premarket https://seekingalpha.com/news/3321177-cellect-bios-apograft-stem-cells-completely-accepted-first-blood-cancer-patients-in-phase-1-2?source=tweet\" data-url=\"https://seekingalpha.com/news/3321177-cellect-bios-apograft-stem-cells-completely-accepted-first-blood-cancer-patients-in-phase-1-2\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:21 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3321176\" data-ts=\"1515075662\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3321176-premarket-gainers-of-9-05\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Premarket Gainers as of 9:05 am</a></h4><ul>     <li><a href='https://seekingalpha.com/symbol/CNET' title='ChinaNet Online Holdings, Inc.'>CNET</a> <font color='green'>+203%</font>&nbsp;on <a href=\"https://seekingalpha.com/pr/17037730-chinanet-online-holdings-announces-strategic-partnership-jingtum-technology\" target=\"_blank\">announcing</a> a strategic partnership with Wuxi Jingtum Network Technology.</li>     <li><a href='https://seekingalpha.com/symbol/APOP' title='Cellect Biotechnology Ltd.'>APOP</a> <font color='green'>+86%</font>&nbsp;on <a href=\"https://seekingalpha.com/pr/17037739-cellect-announces-breakthrough-clinical-results\" target=\"_blank\">breakthrough</a> in clinical results.</li>     <li><a href='https://seekingalpha.com/symbol/FTFT' title='Future Fintech Group Inc'>FTFT</a> <font color='green'>+43%</font>&nbsp;on <a href=\"https://seekingalpha.com/pr/17038024-future-fintech-announces-5-percent-stake-blockchain-technology-company\" target=\"_blank\">5% Stake</a> in Blockchain Technology Company.</li>     <li>COGT&nbsp;<font color='green'>+26%</font>&nbsp;on strategic blockchain <a href=\"https://seekingalpha.com/news/3321105-cogint-announces-strategic-blockchain-alliance\" target=\"_blank\">alliance</a>.</li>     <li>HTGM&nbsp;<font color='green'>+22%</font>&nbsp;on big <a href=\"https://seekingalpha.com/news/3321169-htg-molecular-sees-big-increase-q4-revenues-expects-strong-growth-2018-shares-27-percent\" target=\"_blank\">increase</a> in Q4 revenues and expects strong growth in 2018.</li>     <li>APHB&nbsp;<font color='green'>+21%</font>&nbsp;on significant treatment <a href=\"https://seekingalpha.com/news/3321031-ampliphis-bacteriophage-candidates-show-significant-treatment-benefits-expanded-access-study\" target=\"_blank\">benefits</a> in expanded access study.</li>     <li><a href='https://seekingalpha.com/symbol/CMCM' title='Cheetah Mobile Inc.'>CMCM</a> <font color='green'>+19%</font>.</li>     <li>CLSN&nbsp;<font color='green'>+14%</font>&nbsp;on Phase 1/2 <a href=\"https://seekingalpha.com/news/3321159-fda-signs-phase-1-2-study-celsions-genminus-1-ovarian-cancer-shares-ahead-24-percent\" target=\"_blank\">study</a> of Celsion's GEN-1 in ovarian cancer.</li>     <li>MARK&nbsp;<font color='green'>+9%</font>&nbsp;on FinTech product <a href=\"https://seekingalpha.com/news/3321161-remark-holdings-plus-7_1-percent-fintech-product-launch-new-bank-contracts\" target=\"_blank\">launch</a>.</li>     <li><a href='https://seekingalpha.com/symbol/NXTD' title='NXT-ID Inc.'>NXTD</a> <font color='green'>+8%</font>.</li>     <li><a href='https://seekingalpha.com/symbol/USAU' title='U.S. Gold Corp.'>USAU</a> <font color='green'>+8%</font>.</li>     <li><a href='https://seekingalpha.com/symbol/OTIV' title='On Track Innovations Ltd'>OTIV</a> <font color='green'>+8%</font>.</li>     <li><a href='https://seekingalpha.com/symbol/FRO' title='Frontline Ltd.'>FRO</a> <font color='green'>+8%</font>.</li>     <li><a href='https://seekingalpha.com/symbol/NEPT' title='Neptune Wellness Solutions Inc.'>NEPT</a> <font color='green'>+7%</font>.</li>     <li><a href='https://seekingalpha.com/symbol/TEUM' title='Pareteum Corporation'>TEUM</a> <font color='green'>+6%&nbsp;</font>on <a href=\"https://seekingalpha.com/pr/17037769-social-media-provider-enables-smartphone-services-pareteums-global-cloud\" target=\"_blank\">agreement</a> to provide customer-branded services for a social media application service provider.</li>     <li><a href='https://seekingalpha.com/symbol/JMEI' title='Jumei International Holding Limited'>JMEI</a> <font color='green'>+6%</font>.</li>     <li><a href='https://seekingalpha.com/symbol/RACE' title='Ferrari N.V.'>RACE</a> <font color='green'>+5%</font>.</li>     <li><a href='https://seekingalpha.com/symbol/FCAU' title='Fiat Chrysler Automobiles NV'>FCAU</a> <font color='green'>+5%</font>.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3321176\" data-linked=\"Premarket Gainers as of 9:05 am\" data-tweet=\"$CNET $APOP $FTFT - Premarket Gainers as of 9:05 am https://seekingalpha.com/news/3321176-premarket-gainers-of-9-05?source=tweet\" data-url=\"https://seekingalpha.com/news/3321176-premarket-gainers-of-9-05\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:21 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3321175\" data-ts=\"1515075252\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/S\" target=\"_blank\">S</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3321175-altices-combes-replaces-robbiati-sprints-cfo\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Altice&#39;s Combes replaces Robbiati as Sprint&#39;s CFO</a></h4><ul>   <li>Sprint (NYSE:<a href='https://seekingalpha.com/symbol/S' title='Sprint Corporation'>S</a>) has named former Altice (<a href='https://seekingalpha.com/symbol/ATCEY' title='ALTICE S A ADR'>OTCPK:ATCEY</a>) CEO Michel Combes as its <a href=\"https://seekingalpha.com/pr/17038026-sprint-names-accomplished-telecom-cable-industry-executive-michel-combes-president-and-chief\" target=\"_blank\">new president and chief financial officer</a>, effective this Saturday.</li>    <li>He's replacing Tarek Robbiati, who's exiting the company Jan. 31.</li>    <li>Combes will also join Sprint's board at a later date.</li><li>Sprint's shares had been halted for news and are flat premarket.</li><li>As the former CEO of Alcatel-Lucent, Combes had helped engineer that company's sale to Nokia. Previously he had served as CFO for France Telecom, as well as CEO of Vodafone Europe and CEO of French tower company TDF. He had also worked as an advisor to Brightstar, the company founded by current Sprint chief Marcelo Claure.</li><li>Combes resigned his top job at Altice in November after the company reported heavy customer losses in France.</li><li><strong>Updated 9:47 a.m.:</strong>&nbsp;Sprint's shares are on the slide, <font color='red'>down 5.7%</font> and hovering closer to 52-week lows.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3321175\" data-linked=\"Altice&#39;s Combes replaces Robbiati as Sprint&#39;s CFO\" data-tweet=\"$S $S $ATCEY - Altice&#39;s Combes replaces Robbiati as Sprint&#39;s CFO https://seekingalpha.com/news/3321175-altices-combes-replaces-robbiati-sprints-cfo?source=tweet\" data-url=\"https://seekingalpha.com/news/3321175-altices-combes-replaces-robbiati-sprints-cfo\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:14 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>29&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3321174\" data-ts=\"1515075165\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/TSLA\" target=\"_blank\">TSLA</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3321174-tesla-in-focus-after-model-3-production-target-pushed-back\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Tesla in focus after Model 3 production target pushed back</a></h4><ul> <li>Tesla (NASDAQ:<a href='https://seekingalpha.com/symbol/TSLA' title='Tesla, Inc.'>TSLA</a>) is <font color='red'>down 2.61%</font>&nbsp;premarket after pushing back a closely-watched production target of hitting a 5K Model 3s per week pace to the end of the second quarter.</li> <li>Morgan Stanley analyst Adam Jonas sees the delay<a href=\"https://ca.reuters.com/article/businessNews/idCAKBN1ET1FW-OCABS\" target=\"_blank\"> setting up</a> a very strong Q2 for the EV automaker in terms of production, while Nomura Instinet reminds that prioritizing quality control makes sense. RBC Capital says the shortfall leaves the company \"hovering\" with $1B in cash, but not to the point that it needs a capital raise quite yet.</li> <li>There were some signs of progress on Model 3 production in Q4. \"In the last seven working days of the quarter, we made 793 Model 3s, and in the last few days, we hit a production rate on each of our manufacturing lines that extrapolates to over 1,000 Model 3s per week,\" updated Tesla.</li><li>Previously: <a href=\"https://seekingalpha.com/news/3321034-tesla-q4-model-3-deliveries-well-shy-estimates-shares-1_2-percent\" target=\"_blank\">Tesla Q4 Model 3 deliveries well shy of estimates; shares down 1.2%</a> (Jan. 3)</li> </ul><div class=\"tiny-share-widget\" data-id=\"3321174\" data-linked=\"Tesla in focus after Model 3 production target pushed back\" data-tweet=\"$TSLA - Tesla in focus after Model 3 production target pushed back https://seekingalpha.com/news/3321174-tesla-in-focus-after-model-3-production-target-pushed-back?source=tweet\" data-url=\"https://seekingalpha.com/news/3321174-tesla-in-focus-after-model-3-production-target-pushed-back\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:12 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>134&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3321172\" data-ts=\"1515075027\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3321172-premarket-losers-of-9-05\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Premarket Losers as of 9:05 am</a></h4><ul>     <li><a href='https://seekingalpha.com/symbol/LB' title='L Brands, Inc.'>LB</a>&nbsp;<font color='red'>-10%</font>&nbsp;on <a href=\"https://seekingalpha.com/news/3321125-l-brands-sales-call-highlights\" target=\"_blank\">reporting</a> December 2017 sales and updating Q4 earnings guidance.</li><li><a href='https://seekingalpha.com/symbol/REXX' title='Rex Energy Corporation'>REXX</a> <font color='red'>-9%</font>.</li><li><a href='https://seekingalpha.com/symbol/RENN' title='Renren Inc.'>RENN</a> <font color='red'>-7%</font>.</li><li><a href='https://seekingalpha.com/symbol/ROKU' title='Roku Inc.'>ROKU</a>&nbsp;<font color='red'>-6%</font>&nbsp;as&nbsp;Morgan Stanley <a href=\"https://seekingalpha.com/news/3321141-roku-7-percent-morgan-stanley-cuts-underweight\" target=\"_blank\">cuts</a> to underweight.</li><li><a href='https://seekingalpha.com/symbol/RAD' title='Rite Aid Corporation'>RAD</a>&nbsp;<font color='red'>-6%</font>&nbsp;on <a href=\"https://seekingalpha.com/news/3321032-rite-aid-beats-0_02\" target=\"_blank\">Q3 earnings</a>.</li><li>FH <font color='red'>-6%</font>.</li>  </ul><div class=\"tiny-share-widget\" data-id=\"3321172\" data-linked=\"Premarket Losers as of 9:05 am\" data-tweet=\"$LB $REXX $RENN - Premarket Losers as of 9:05 am https://seekingalpha.com/news/3321172-premarket-losers-of-9-05?source=tweet\" data-url=\"https://seekingalpha.com/news/3321172-premarket-losers-of-9-05\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:10 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3321169\" data-ts=\"1515074487\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/HTGM\" target=\"_blank\">HTGM</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3321169-htg-molecular-sees-big-increase-in-q4-revenues-and-expects-strong-growth-in-2018-shares-up-27\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">HTG Molecular sees big increase in Q4 revenues and expects strong growth in 2018; shares up 27% premarket</a></h4><ul><li>Nano cap HTG Molecular Diagnostics (NASDAQ:<a href='https://seekingalpha.com/symbol/HTGM' title='HTG Molecular Diagnostics'>HTGM</a>) is up&nbsp;<font color='green'>27%</font>&nbsp;premarket on increased volume in response to its <a href=\"https://seekingalpha.com/pr/17037859-htg-announces-preliminary-fourth-quarter-full-year-2017-unaudited-financial-results-provides\" target=\"_blank\">updated guidance</a>.</li><li><strong>Q4 2017</strong>: revenue should be $6.9M - 7.2M, up 373 - 394% from a year ago. Annual revenue should be $13.8M - 14.1M (+169 - 175%).</li><li>Cash and equivalents were ~$10M at year-end 2017.</li><li><strong>2018 revenue guidance</strong>: $20 - 25M.</li></ul><div class=\"tiny-share-widget\" data-id=\"3321169\" data-linked=\"HTG Molecular sees big increase in Q4 revenues and expects strong growth in 2018; shares up 27% premarket\" data-tweet=\"$HTGM - HTG Molecular sees big increase in Q4 revenues and expects strong growth in 2018; shares up 27% premarket https://seekingalpha.com/news/3321169-htg-molecular-sees-big-increase-in-q4-revenues-and-expects-strong-growth-in-2018-shares-up-27?source=tweet\" data-url=\"https://seekingalpha.com/news/3321169-htg-molecular-sees-big-increase-in-q4-revenues-and-expects-strong-growth-in-2018-shares-up-27\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:01 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>2&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3321166\" data-ts=\"1515074170\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/LW\" target=\"_blank\">LW</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3321166-lamb-weston-beats-estimates\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Lamb Weston beats estimates</a></h4><ul>     <li>Lamb Weston (NYSE:<a href='https://seekingalpha.com/symbol/LW' title='Lamb Weston Holdings, Inc.'>LW</a>) reports volume fell 1% in <a href=\"https://seekingalpha.com/pr/17037944-lamb-weston-holdings-inc-reports-fiscal-second-quarter-2018-results-updates-full-year-outlook\" target=\"_blank\">Q2</a>.</li>     <li>Price/mix increased 5% due to pricing actions and favorable product and customer mix.</li>     <li>Segment sales: Global: $416.9M (+1%); Foodservice: $272.8M (+9%); Retail: $102M (+6%); Other: $32.9M (+6%).</li>     <li>Adjusted operating margin&nbsp; rate improved 40 bps to 17.4%.</li>     <li>Adjusted EBITDA grew 12% to $188.9M for the period.</li>     <li><b>FY2018 Guidance</b>: Net sales:&nbsp;increase mid-single digits;&nbsp;Adjusted EBITDA:&nbsp;$780M to $790M; Interest expense: $105M to $110M; Capex: ~$250M.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3321166\" data-linked=\"Lamb Weston beats estimates\" data-tweet=\"$LW - Lamb Weston beats estimates https://seekingalpha.com/news/3321166-lamb-weston-beats-estimates?source=tweet\" data-url=\"https://seekingalpha.com/news/3321166-lamb-weston-beats-estimates\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  8:56 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3321164\" data-ts=\"1515073760\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/ARCT\" target=\"_blank\">ARCT</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3321164-arcturus-teams-up-curevac-to-develop-and-commercialize-mrna-therapeutics-shares-ahead-5\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Arcturus teams up with CureVac to develop and commercialize mRNA therapeutics; shares ahead 5% premarket</a></h4><ul><li>Thinly traded nano cap Arcturus Therapeutics (NASDAQ:<a href='https://seekingalpha.com/symbol/ARCT' title='Arcturus Therapeutics Ltd.'>ARCT</a>) is up&nbsp;<font color='green'>5%</font>&nbsp;premarket on light volume on the heels of its strategic <a href=\"https://seekingalpha.com/pr/17037635-curevac-arcturus-therapeutics-announce-broad-strategic-collaboration-advance-next-generation\" target=\"_blank\">collaboration </a>with CureVac AG to discover, develop and commercialize new messenger RNA (mRNA) therapeutics.</li><li>The companies will work together to develop up to four candidates for rare diseases leveraging CureVac's optimized natural mRNA sequence (RNAoptimizer) and Arcturus' lipid-mediated nucleic acid delivery system &#40;LUNAR&#41;. The therapeutic focus will be on enzyme replacement and antibody generation. First up will be ornithine transcarbamylase deficiency, an inherited disorder characterized by the buildup of ammonia in the blood.</li><li>Under the terms of the partnership, development costs will be shared. Products will be co-commercialized under a profit-sharing arrangement. Specific financial terms are not disclosed.</li></ul><div class=\"tiny-share-widget\" data-id=\"3321164\" data-linked=\"Arcturus teams up with CureVac to develop and commercialize mRNA therapeutics; shares ahead 5% premarket\" data-tweet=\"$ARCT - Arcturus teams up with CureVac to develop and commercialize mRNA therapeutics; shares ahead 5% premarket https://seekingalpha.com/news/3321164-arcturus-teams-up-curevac-to-develop-and-commercialize-mrna-therapeutics-shares-ahead-5?source=tweet\" data-url=\"https://seekingalpha.com/news/3321164-arcturus-teams-up-curevac-to-develop-and-commercialize-mrna-therapeutics-shares-ahead-5\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  8:49 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3321162\" data-ts=\"1515073535\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/DPZ\" target=\"_blank\">DPZ</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3321162-dominos-called-best-growth-story-in-retail\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Domino&#39;s called the best growth story in retail</a></h4><ul> <li>Credit Suisse upgrades Domino's Pizza (NYSE:<a href='https://seekingalpha.com/symbol/DPZ' title='Domino&#39;s Pizza, Inc.'>DPZ</a>)&nbsp;to an Outperform rating from Neutral on its view that the company is still one of the \"best growth stories\" in retail.</li> <li>\"DPZ shares have pulled back sharply from recent highs, despite significant upside to forward earnings around tax reform. With the relative P/E multiple now ~30% below the 2-yr. avg. we believe concerns around a 4Q sales miss and incremental delivery competition are priced in,\" writes analyst Jason West.</li> <li>The new price target from CS on Domino's is $220.</li> <li>Shares of Domino's are <font color='green'>up 2.46%</font> in premarket trading to $196.37.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3321162\" data-linked=\"Domino&#39;s called the best growth story in retail\" data-tweet=\"$DPZ - Domino&#39;s called the best growth story in retail https://seekingalpha.com/news/3321162-dominos-called-best-growth-story-in-retail?source=tweet\" data-url=\"https://seekingalpha.com/news/3321162-dominos-called-best-growth-story-in-retail\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  8:45 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>4&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3321161\" data-ts=\"1515073478\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/MARK\" target=\"_blank\">MARK</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3321161-remark-holdingsplus-7_1-on-fintech-product-launch-new-bank-contracts\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Remark Holdings +7.1% on FinTech product launch, new bank contracts</a></h4><ul><li>        Remark Holdings&rsquo; (NASDAQ:<a href='https://seekingalpha.com/symbol/MARK' title='Remark Holdings, Inc.'>MARK</a>) KanKan business <a href=\"http://ir.remarkholdings.com/releasedetail.cfm?ReleaseID=1053322\" target=\"_blank\">launches</a> a credit-related FinTech product to improve bank risk-management systems for better accuracy and efficiency when determining client credit quality.</li><li>               Remark also announces receiving contracts from several major Chinese banks with each contract expected to generate millions in revenue.&nbsp;</li><li>               Remark shares are&nbsp;<font color='green'>up 7.1%</font>&nbsp;premarket.&nbsp;&nbsp;</li><li>Previously: <a href=\"https://seekingalpha.com/news/3319129-remark-holdings-announces-4m-kankan-agreement\" target=\"_blank\">Remark Holdings announces $4M KanKan agreement</a> (Dec. 19, 2017)</li></ul><div class=\"tiny-share-widget\" data-id=\"3321161\" data-linked=\"Remark Holdings +7.1% on FinTech product launch, new bank contracts\" data-tweet=\"$MARK - Remark Holdings +7.1% on FinTech product launch, new bank contracts https://seekingalpha.com/news/3321161-remark-holdingsplus-7_1-on-fintech-product-launch-new-bank-contracts?source=tweet\" data-url=\"https://seekingalpha.com/news/3321161-remark-holdingsplus-7_1-on-fintech-product-launch-new-bank-contracts\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  8:44 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>3&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3321160\" data-ts=\"1515073008\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/GBTC\" target=\"_blank\">GBTC</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3321160-ripple-up-another-20-blows-past-ether-sights-set-on-bitcoin\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Ripple up another 20%, blows past Ether, sights set on Bitcoin</a></h4><ul><li>At the current price of $3.25, Ripple (or XRP) has a market cap of more than $120B, making it the 2nd most valuable crypto out there. At $245B, Bitcoin remains number one for the moment.</li><li>Ripple is<font color='green'> up 65%</font>&nbsp;just in 2018, and nearly<font color='green'> 14-fold</font>&nbsp;over the last month. Over the past year, it's&nbsp;<font color='green'>up 300-fold</font>.</li><li>The Ripple technology hopes to bring blockchain benefits to financial institutions, enabling cross-border payments at a far lower cost than the current system.</li><li>Adding in coins not in circulation, Ripple is worth $380B, <a href=\"https://twitter.com/novogratz\" target=\"_blank\">says a wary Mike Novogratz</a>. He reminds of the peak of the Japanese property bubble, when the land under the Imperial Palace was valued at more than the entire state of California. At that $380B valuation, Ripple Labs, he says, is worth $225B, making it the globe's 10th most-valuable company. CEO Chris Larsen is worth $55B, tying Mark Zuckerburg as the 5th-wealthiest person on the planet. \"Things that don't make sense don't last....be careful out there.\"</li><li>Related tickers: <a href='https://seekingalpha.com/symbol/GBTC' title='Grayscale Bitcoin Trust &#40;BTC&#41;'>OTCQX:GBTC</a>, <a href='https://seekingalpha.com/symbol/COIN' title='Winklevoss Bitcoin Trust ETF'>COIN</a>, <a href='https://seekingalpha.com/symbol/RIOT' title='Riot Blockchain, Inc.'>RIOT</a>, <a href='https://seekingalpha.com/symbol/OSTK' title='Overstock.com, Inc.'>OSTK</a>, <a href='https://seekingalpha.com/symbol/SSC-OLD' title='Seven Stars Cloud Group, Inc.'>SSC-OLD</a>, <a href='https://seekingalpha.com/symbol/MARA' title='Marathon Patent Group, Inc.'>MARA</a>, <a href='https://seekingalpha.com/symbol/UEPS' title='Net 1 UEPS Technologies, Inc.'>UEPS</a>, <a href='https://seekingalpha.com/symbol/BITCF' title='First Bitcoin Capital Corp.'>OTC:BITCF</a>, <a href='https://seekingalpha.com/symbol/XNET' title='Xunlei Limited'>XNET</a>, <a href='https://seekingalpha.com/symbol/GROW' title='U.S. Global Investors, Inc.'>GROW</a>, <a href='https://seekingalpha.com/symbol/BTSC' title='Bitcoin Services, Inc.'>OTCPK:BTSC</a>, <a href='https://seekingalpha.com/symbol/BTCS' title='BTCS Inc.'>OTCQB:BTCS</a>, <a href='https://seekingalpha.com/symbol/MGTI' title='MGT Capital Investments, Inc.'>OTCQB:MGTI</a>, <a href='https://seekingalpha.com/symbol/BTLLF' title='Interbit Ltd.'>OTCPK:BTLLF</a> <a href='https://seekingalpha.com/symbol/SRAX' title='Social Reality Inc.'>SRAX</a>, <a href='https://seekingalpha.com/symbol/GAHC' title='Global Arena Holding, Inc.'>OTCPK:GAHC</a>, <a href='https://seekingalpha.com/symbol/UBIA' title='UBI BlockChain Internet Ltd.'>OTC:UBIA</a>, <a href='https://seekingalpha.com/symbol/ARSC' title='American Security Resources Corp.'>OTC:ARSC</a>, <a href='https://seekingalpha.com/symbol/USTC' title='USA Real Estate Holding Co'>OTCPK:USTC</a>, PRELF, <a href='https://seekingalpha.com/symbol/BLKCF' title='Global Blockchain Technologies Corp.'>OTCPK:BLKCF</a>, <a href='https://seekingalpha.com/symbol/CRCW' title='The Crypto Company'>OTC:CRCW</a>, <a href='https://seekingalpha.com/symbol/COINB' title='Coinbase'>COINB</a>, <a href='https://seekingalpha.com/symbol/LFIN' title='LongFin Corp.A'>OTCPK:LFIN</a></li></ul><div class=\"tiny-share-widget\" data-id=\"3321160\" data-linked=\"Ripple up another 20%, blows past Ether, sights set on Bitcoin\" data-tweet=\"$GBTC $GBTC $COIN - Ripple up another 20%, blows past Ether, sights set on Bitcoin https://seekingalpha.com/news/3321160-ripple-up-another-20-blows-past-ether-sights-set-on-bitcoin?source=tweet\" data-url=\"https://seekingalpha.com/news/3321160-ripple-up-another-20-blows-past-ether-sights-set-on-bitcoin\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  8:36 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>131&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3321159\" data-ts=\"1515072830\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/CLSN\" target=\"_blank\">CLSN</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3321159-fda-signs-off-on-phase-1-2-study-of-celsions-genminus-1-in-ovarian-cancer-shares-ahead-24\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">FDA signs off on Phase 1/2 study of Celsion&#39;s GEN-1 in ovarian cancer; shares ahead 24% premarket</a></h4><ul><li>Nano cap Celsion (NASDAQ:<a href='https://seekingalpha.com/symbol/CLSN' title='Celsion Corporation'>CLSN</a>) is up&nbsp;<font color='green'>24%</font>&nbsp;premarket on increased volume on the heels of its <a href=\"https://seekingalpha.com/pr/17037848-celsion-announces-fda-clearance-ovation-ii-study-evaluation-genminus-1-immunotherapy-treat\" target=\"_blank\">announcement </a>that the FDA is on board with its Phase 1/2 clinical trial assessing DNA-based immunotherapeutic GEN-1 for the localized treatment of ovarian cancer. Enrollment should commence in H1 with 25% of the target participating by year-end.</li><li><a href=\"http://celsion.com/gen-1/\" target=\"_blank\">GEN-1</a>&nbsp;is an interleukin 12 (IL-12) DNA plasmid vector encased in a nanoparticle delivery system, a technology platform the company calls&nbsp;<a href=\"http://celsion.com/theraplas/\" target=\"_blank\">TheraPlas</a>. It is designed to stimulate the local production and secretion of IL-12, a potent inducer of anti-cancer immunity, around the tumor site.</li></ul><div class=\"tiny-share-widget\" data-id=\"3321159\" data-linked=\"FDA signs off on Phase 1/2 study of Celsion&#39;s GEN-1 in ovarian cancer; shares ahead 24% premarket\" data-tweet=\"$CLSN - FDA signs off on Phase 1/2 study of Celsion&#39;s GEN-1 in ovarian cancer; shares ahead 24% premarket https://seekingalpha.com/news/3321159-fda-signs-off-on-phase-1-2-study-of-celsions-genminus-1-in-ovarian-cancer-shares-ahead-24?source=tweet\" data-url=\"https://seekingalpha.com/news/3321159-fda-signs-off-on-phase-1-2-study-of-celsions-genminus-1-in-ovarian-cancer-shares-ahead-24\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  8:33 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>7&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3321157\" data-ts=\"1515072737\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/M\" target=\"_blank\">M</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3321157-macys-updates-on-store-closings\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Macy&#39;s updates on store closings</a></h4><ul> <li>Macy's (NYSE:<a href='https://seekingalpha.com/symbol/M' title='Macy&#39;s Inc.'>M</a>) says it <a href=\"https://seekingalpha.com/pr/17037797-macy-s-inc-reports-positive-comp-sales-november-december\" target=\"_blank\">closed</a> another 11 stores, including 4 stores previously disclosed.</li> <li>The latest round of closures brings the company's tally to 81 out of 100 planned closings.</li> <li>Macy's says that it intends to close approximately 19 additional stores as leases or operating covenants expire or sale transactions are completed.</li><li>Previously: <a href=\"https://seekingalpha.com/news/3321150-macys-lower-holiday-sales-update\" target=\"_blank\">Macy's lower after holiday sales update</a> (Jan. 4)</li><li>Shares of Macy's are&nbsp;<font color='red'>down 1.78%</font>&nbsp;in premarket trading.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3321157\" data-linked=\"Macy&#39;s updates on store closings\" data-tweet=\"$M - Macy&#39;s updates on store closings https://seekingalpha.com/news/3321157-macys-updates-on-store-closings?source=tweet\" data-url=\"https://seekingalpha.com/news/3321157-macys-updates-on-store-closings\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  8:32 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>8&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3321155\" data-ts=\"1515072721\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/FFIV\" target=\"_blank\">FFIV</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3321155-f5-networks-up-on-analyst-upgrade-new-street-high-price-target\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">F5 Networks up on analyst upgrade, new Street-high price target</a></h4><ul><li>        BMO upgrades F5 Networks (NASDAQ:<a href='https://seekingalpha.com/symbol/FFIV' title='F5 Networks, Inc.'>FFIV</a>) from Market Perform to Outperform and sets the price target at the new Street high of $156, up from $122.</li><li>               Analyst Tim Long expects shares to turn around after a 2017 underperformance as investors give more credit to the recurring software business.&nbsp;</li><li>               Long expects product growth reacceleration in mid-2018 and notes that the company will be one of the largest beneficiaries of the U.S. tax reform with a 31% pro forma tax rate.&nbsp;</li><li>               Source: Bloomberg First Word&nbsp;</li><li>               F5 shares are&nbsp;<font color='green'>up 0.1%</font>&nbsp;premarket to $134.11.&nbsp;&nbsp;</li></ul><div class=\"tiny-share-widget\" data-id=\"3321155\" data-linked=\"F5 Networks up on analyst upgrade, new Street-high price target\" data-tweet=\"$FFIV - F5 Networks up on analyst upgrade, new Street-high price target https://seekingalpha.com/news/3321155-f5-networks-up-on-analyst-upgrade-new-street-high-price-target?source=tweet\" data-url=\"https://seekingalpha.com/news/3321155-f5-networks-up-on-analyst-upgrade-new-street-high-price-target\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  8:32 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3321145\" data-ts=\"1515072186\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/CCXI\" target=\"_blank\">CCXI</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3321145-chemocentryx-marketing-application-for-avacopan-in-anca-vasculitis-accepted-for-review-in\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">ChemoCentryx marketing application for avacopan in ANCA vasculitis accepted for review in Europe; shares up 18% premarket</a></h4><ul><li>The European Medicines Agency <a href=\"https://seekingalpha.com/pr/17037673-avacopan-conditional-marketing-authorization-application-accepted-regulatory-review-european\" target=\"_blank\">accepts for review</a> ChemoCentryx's (NASDAQ:<a href='https://seekingalpha.com/symbol/CCXI' title='ChemoCentryx'>CCXI</a>) marketing application seeking approval for avacopan for the treatment of patients with anti-neutrophil cytoplasmic antibody-associated vasculitis (<a href=\"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3095854/\" target=\"_blank\">ANCA vasculitis</a>), a disorder characterized by tissue-destroying (necrotizing) inflammation of small vessels.</li><li>The action triggers a $50M milestone payment from alliance partner Vifor Fresenius Medical Care Renal Pharma.</li><li>Small molecule avacopan inhibits the complement C5a receptor which plays a key role in the inflammatory process.</li><li>Concurrently, the company has secured $50M of <a href=\"https://seekingalpha.com/pr/17037694-chemocentryx-secures-100-million-new-capital-commitments\" target=\"_blank\">financing </a>from Hercules Capital which will fund the advancement of avacopan.</li><li>Shares are up&nbsp;<font color='green'>18%&nbsp;</font>premarket on light volume.</li></ul><div class=\"tiny-share-widget\" data-id=\"3321145\" data-linked=\"ChemoCentryx marketing application for avacopan in ANCA vasculitis accepted for review in Europe; shares up 18% premarket\" data-tweet=\"$CCXI - ChemoCentryx marketing application for avacopan in ANCA vasculitis accepted for review in Europe; shares up 18% premarket https://seekingalpha.com/news/3321145-chemocentryx-marketing-application-for-avacopan-in-anca-vasculitis-accepted-for-review-in?source=tweet\" data-url=\"https://seekingalpha.com/news/3321145-chemocentryx-marketing-application-for-avacopan-in-anca-vasculitis-accepted-for-review-in\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  8:23 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>2&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3321150\" data-ts=\"1515071918\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/M\" target=\"_blank\">M</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3321150-macys-lower-after-holiday-sales-update\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Macy&#39;s lower after holiday sales update</a></h4><ul>     <li>Macy&rsquo;s (NYSE:<a href='https://seekingalpha.com/symbol/M' title='Macy&#39;s Inc.'>M</a>) announces that comparable sales on an       owned basis increased 1.0% for the two-month holiday period,</li>     <li>On an owned plus       licensed basis, comparable sales increased 1.1% for the period.</li>     <li>\"We saw improved sales trends in our stores and continued to       see double-digit growth on our digital platforms. Customers also       responded well to our new loyalty program,\" says Macy's CEO Jeff Gennette.</li>     <li>Macy&rsquo;s narrows the range of its previous comparable sales on an owned       basis guidance to -2.4% to -2.7%. Total sales are expected to be down between 3.6% and       3.9% in FY17. Full-year EPS of $3.11 to $3.21 is expected after factoring in the Union Square deal and tax reform changes.</li><li>Shares of Macy's are&nbsp;<font color='red'>down 2.49%</font>&nbsp;premarket to $24.70.</li>     <li>Source: <a href=\"https://seekingalpha.com/pr/17037797-macy-s-inc-reports-positive-comp-sales-november-december\" target=\"_blank\">Press Release</a></li> </ul><div class=\"tiny-share-widget\" data-id=\"3321150\" data-linked=\"Macy&#39;s lower after holiday sales update\" data-tweet=\"$M - Macy&#39;s lower after holiday sales update https://seekingalpha.com/news/3321150-macys-lower-after-holiday-sales-update?source=tweet\" data-url=\"https://seekingalpha.com/news/3321150-macys-lower-after-holiday-sales-update\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  8:18 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>45&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3321146\" data-ts=\"1515071491\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/ULTA\" target=\"_blank\">ULTA</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3321146-m-hunch-ulta-beauty-on-amazon-shopping-list\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">M&amp;A hunch: Ulta Beauty on Amazon shopping list</a></h4><ul> <li>Shares of Ulta Beauty (NASDAQ:<a href='https://seekingalpha.com/symbol/ULTA' title='Ulta Beauty, Inc.'>ULTA</a>) are on watch after a new note from Moness Crespi Hardt speculates that the company may be the next target for Amazon.</li><li>It's not the first time the AMZN-ULTA idea has been bandied around.</li> <li>ULTA <font color='green'>+1.22%</font> premarket to $248.10.</li>  </ul><div class=\"tiny-share-widget\" data-id=\"3321146\" data-linked=\"M&amp;A hunch: Ulta Beauty on Amazon shopping list\" data-tweet=\"$ULTA - M&amp;A hunch: Ulta Beauty on Amazon shopping list https://seekingalpha.com/news/3321146-m-hunch-ulta-beauty-on-amazon-shopping-list?source=tweet\" data-url=\"https://seekingalpha.com/news/3321146-m-hunch-ulta-beauty-on-amazon-shopping-list\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  8:11 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>6&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3321144\" data-ts=\"1515071396\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/WDC\" target=\"_blank\">WDC</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3321144-western-digitalminus-1_6-on-analyst-downgrade-price-target-cut\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Western Digital -1.6% on analyst downgrade, price target cut</a></h4><ul><li>        BMO Capital <a href=\"https://www.google.com/url?sa=t&amp;rct=j&amp;q=&amp;esrc=s&amp;source=web&amp;cd=2&amp;cad=rja&amp;uact=8&amp;ved=0ahUKEwj7zOnZrr7YAhUK84MKHdrDC2QQFggqMAE&amp;url=https%3A%2F%2Fwww.streetinsider.com%2FAnalyst%2BPT%2BChange%2FBMO%2BCapital%2BDowngrades%2BWestern%2BDigital%2BCorp.%2B%28WDC%29%2Bto%2BMarket%2BPerform%2C%2BCycle%2BPeak%2Bto%2BKeep%2BStock%2BRange-Bound%2F13652582.html&amp;usg=AOvVaw3eKEwv7qP2KY-MoDCv7l37\" target=\"_blank\">downgrades</a> Western Digital (NYSE:<a href='https://seekingalpha.com/symbol/WDC' title='Western Digital Corporation'>WDC</a>) from Outperform to Market Perform and drops the price target from $120 to $85.</li><li>           Western Digital shares are&nbsp;<font color='red'>down 1.6%</font>&nbsp;premarket to $81.36. </li><li>Previously: <a href=\"https://seekingalpha.com/news/3320988-benchmark-wdc-nvda-adding-fuel-risc-v-movement\" target=\"_blank\">Benchmark: WDC, NVDA adding fuel to RISC-V movement</a> (Jan. 3)</li></ul><div class=\"tiny-share-widget\" data-id=\"3321144\" data-linked=\"Western Digital -1.6% on analyst downgrade, price target cut\" data-tweet=\"$WDC - Western Digital -1.6% on analyst downgrade, price target cut https://seekingalpha.com/news/3321144-western-digitalminus-1_6-on-analyst-downgrade-price-target-cut?source=tweet\" data-url=\"https://seekingalpha.com/news/3321144-western-digitalminus-1_6-on-analyst-downgrade-price-target-cut\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  8:09 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>36&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3321141\" data-ts=\"1515071318\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/ROKU\" target=\"_blank\">ROKU</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3321141-roku-down-7-morgan-stanley-cuts-to-underweight\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Roku down 7% as Morgan Stanley cuts to Underweight</a></h4><ul><li>A tripling in the stock price over the past two months makes Roku's (NASDAQ:<a href='https://seekingalpha.com/symbol/ROKU' title='Roku Inc.'>ROKU</a>) valuation \"hard to justify,\" says analyst Ben Swinburne, downgrading to Underweight, with $30 price target suggesting&nbsp;<font color='red'>almost 50% downside</font>&nbsp;from yesterday's close.</li><li>Netflix, he says, isn't an appropriate comp for Roku for a number of reasons. Among them, hardware sales are expected to account for nearly half of Roku revenue this year, and they generate minimal profits.</li><li>Source: Bloomberg's Arie Shapira</li><li>Shares&nbsp;<font color='red'>-7.3%</font>&nbsp;premarket to $51.38.</li></ul><div class=\"tiny-share-widget\" data-id=\"3321141\" data-linked=\"Roku down 7% as Morgan Stanley cuts to Underweight\" data-tweet=\"$ROKU - Roku down 7% as Morgan Stanley cuts to Underweight https://seekingalpha.com/news/3321141-roku-down-7-morgan-stanley-cuts-to-underweight?source=tweet\" data-url=\"https://seekingalpha.com/news/3321141-roku-down-7-morgan-stanley-cuts-to-underweight\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  8:08 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>30&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3321132\" data-ts=\"1515070724\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/BOLD\" target=\"_blank\">BOLD</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3321132-audentes-gene-therapy-at132-shows-positive-effect-in-xlmtm-study-shares-ahead-13-premarket\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Audentes&#39; gene therapy AT132 shows positive effect in XLMTM study; shares ahead 13% premarket</a></h4><ul><li>Thinly traded Audentes Therapeutics (NASDAQ:<a href='https://seekingalpha.com/symbol/BOLD' title='Audentes Therapeutics'>BOLD</a>) is up&nbsp;<font color='green'>13%</font>&nbsp;premarket on light volume in response to its <a href=\"https://seekingalpha.com/pr/17037660-audentes-announces-positive-interim-data-first-dose-cohort-aspiro-phase-1-2-clinical-trial\" target=\"_blank\">announcement </a>of positive preliminary results from a Phase 1/2 clinical trial, ASPIRO, assessing gene therapy candidate AT132 in patients with X-Linked Myotubular Myopathy &#40;XLMTM&#41;, an inherited disorder characterized by extreme muscle weakness, respiratory failure and early death.</li><li>Results from the first dose cohort at week 12 showed patient #1 improved from a severely compromised baseline to almost a normal range.</li><li>On the safety front, six adverse events were reported, two serious. One of the serious AEs, gastrointestinal infection and elevated troponin levels in Patient #3, was probably treatment-related (elevated troponin level effect only). Two of the four non-serious AEs were possibly treatment-related (elevated bilirubin and elevated liver enzymes).</li><li>Management will host a conference call momentarily to discuss the data.</li></ul><div class=\"tiny-share-widget\" data-id=\"3321132\" data-linked=\"Audentes&#39; gene therapy AT132 shows positive effect in XLMTM study; shares ahead 13% premarket\" data-tweet=\"$BOLD - Audentes&#39; gene therapy AT132 shows positive effect in XLMTM study; shares ahead 13% premarket https://seekingalpha.com/news/3321132-audentes-gene-therapy-at132-shows-positive-effect-in-xlmtm-study-shares-ahead-13-premarket?source=tweet\" data-url=\"https://seekingalpha.com/news/3321132-audentes-gene-therapy-at132-shows-positive-effect-in-xlmtm-study-shares-ahead-13-premarket\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  7:58 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3321123\" data-ts=\"1515069355\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/CVS\" target=\"_blank\">CVS</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3321123-cvs-health-sees-operating-profit-growth-of-1-4-this-year-shares-up-1-premarket\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">CVS Health sees operating profit growth of 1 - 4% this year; shares up 1% premarket</a></h4><ul><li>CVS Health (NYSE:<a href='https://seekingalpha.com/symbol/CVS' title='CVS Health Corporation'>CVS</a>) announces its <a href=\"https://seekingalpha.com/pr/17037621-cvs-health-provides-2018-outlook\" target=\"_blank\">financial outlook</a> for 2018:</li><li>Net revenue growth: 0.75 - 2.5%.</li><li>Non-GAAP consolidated operating profit growth: 1 - 4%; non-GAAP operating profit growth in Retail/LTC segment: low single-digit; non-GAAP operating profit growth in Pharmacy Services: low-to-mid-single-digit.</li><li>Prescription growth should be 6 - 7%. Same store sales growth: 2.0 - 3.5%.</li><li>Operating profit to be unfavorably impacted by the implementation costs of PBM contract with Anthem (beginning in 2020) as well as recent divestiture of RxCrossroads. Both will reduce non-GAAP operating profit by ~1.25%.</li><li>Aetna transaction should close in H2 but is assumed to close after year-end for guidance purposes. All transaction-related costs will be excluded from non-GAAP figures.</li><li>New tax law should boost cash flow by ~$1.2B.</li><li>$2.00 annual dividend to be maintained.</li><li>Q4 2017 revised guidance: Pharmacy Services growth: mid-teens; operating profit in Retail/TLC: (3.5%) - (1.0%); non-GAAP EPS and non-GAAP consolidated operating profit growth will be at the lower end of the ranges announced during the Q3 earnings call ($1.88 - 1.92 and 5.75 - 8.00%, respectively).</li><li>Management will host a conference call this morning at 11:00 am ET to discuss guidance.</li><li>Shares are up&nbsp;<font color='green'>1%</font>&nbsp;premarket on light volume.</li></ul><div class=\"tiny-share-widget\" data-id=\"3321123\" data-linked=\"CVS Health sees operating profit growth of 1 - 4% this year; shares up 1% premarket\" data-tweet=\"$CVS - CVS Health sees operating profit growth of 1 - 4% this year; shares up 1% premarket https://seekingalpha.com/news/3321123-cvs-health-sees-operating-profit-growth-of-1-4-this-year-shares-up-1-premarket?source=tweet\" data-url=\"https://seekingalpha.com/news/3321123-cvs-health-sees-operating-profit-growth-of-1-4-this-year-shares-up-1-premarket\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  7:35 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>40&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3321122\" data-ts=\"1515069193\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/WBA\" target=\"_blank\">WBA</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3321122-walgreens-boots-revenues-up-8-non-gaap-eps-up-16-in-q1\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Walgreens Boots revenues up 8%; non-GAAP EPS up 16% in Q1</a></h4><ul><li>Walgreens Boots (<a href='https://seekingalpha.com/symbol/WBA' title='Walgreens Boots Alliance, Inc.'>WBA</a> <font color='green'>+0.7%</font>) <a href=\"https://seekingalpha.com/pr/17037637-walgreens-boots-alliance-reports-fiscal-2018-first-quarter-results\" target=\"_blank\">Q1 results</a>: Revenues: $30,740M (+7.9%); Operating Income: $1,322M (-8.6%); Net Income: $821M (-22.1%); EPS: $0.81 (-16.5%); Non-GAAP EPS: $1.28 (+16.4%); Quick Assets: $1,830M (-44.6%); CF Ops: $961M (+83.0%).</li><li><strong>FY2018 Guidance</strong>: Non-GAAP EPS: $5.45 - $5.70.</li><li>Shares are down&nbsp;<font color='red'>2%</font>&nbsp;premarket on light volume.</li></ul><div class=\"tiny-share-widget\" data-id=\"3321122\" data-linked=\"Walgreens Boots revenues up 8%; non-GAAP EPS up 16% in Q1\" data-tweet=\"$WBA - Walgreens Boots revenues up 8%; non-GAAP EPS up 16% in Q1 https://seekingalpha.com/news/3321122-walgreens-boots-revenues-up-8-non-gaap-eps-up-16-in-q1?source=tweet\" data-url=\"https://seekingalpha.com/news/3321122-walgreens-boots-revenues-up-8-non-gaap-eps-up-16-in-q1\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  7:33 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3321120\" data-ts=\"1515068954\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/JCP\" target=\"_blank\">JCP</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3321120-j-c-penney-rallies-after-holiday-sales-update\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">J.C. Penney rallies after holiday sales update</a></h4><ul> <li>J.C. Penney (NYSE:<a href='https://seekingalpha.com/symbol/JCP' title='J.C. Penney Company Inc.'>JCP</a>) reports comparable sales increased 3.4% for the nine-week holiday period ending on December 30. Strength in the home, beauty and fine jewelry categories is cited by management.</li> <li>\"Our ability to execute e-commerce fulfillment from 100% of our brick and mortar stores helped fuel the growth in e-commerce for the holiday season. We remain confident that our strategic initiatives are taking hold and resonating with customers,\" says J.C. Penney CEO Marvin Ellison.</li> <li>The department store operator backs all of its prior guidance along with the sales update.</li> <li><a href=\"http://ir.jcpenney.com/phoenix.zhtml?c=70528&amp;p=irol-newsCompanyArticle&amp;ID=2324824\" target=\"_blank\">J.C. Penney press release</a></li> <li>JCP <font color='green'>+5.95%</font> premarket to $3.92.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3321120\" data-linked=\"J.C. Penney rallies after holiday sales update\" data-tweet=\"$JCP - J.C. Penney rallies after holiday sales update https://seekingalpha.com/news/3321120-j-c-penney-rallies-after-holiday-sales-update?source=tweet\" data-url=\"https://seekingalpha.com/news/3321120-j-c-penney-rallies-after-holiday-sales-update\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  7:29 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>52&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3321115\" data-ts=\"1515068584\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/SNAP\" target=\"_blank\">SNAP</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3321115-snapminus-2_9-after-analyst-downgrade-price-target-reduction\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Snap -2.9% after analyst downgrade, price target reduction</a></h4><ul><li>        Cowen <a href=\"https://www.google.com/url?sa=t&amp;rct=j&amp;q=&amp;esrc=s&amp;source=newssearch&amp;cd=1&amp;ved=0ahUKEwie-9_Go77YAhXr4IMKHf3GBgQQqQIIJSgAMAA&amp;url=https%3A%2F%2Fwww.streetinsider.com%2FAnalyst%2BComments%2FUPDATE%3A%2BCowen%2BDowngrades%2BSnap%2BInc%2B%28SNAP%29%2Bto%2BUnderperform%2BFollowing%2BAd%2BBuyer%2BSurvey%2Band%2BConsumer%2BSurvey%2BResults%2F13652650.html&amp;usg=AOvVaw0QCIhx00guyS_BsM7p0AcP\" target=\"_blank\">downgrades</a> Snap (NYSE:<a href='https://seekingalpha.com/symbol/SNAP' title='Snap Inc.'>SNAP</a>) from Neutral to Underperform and drops the price target by a dollar to $11.</li><li>        Analyst John Blackledge cites the firm&rsquo;s Snap AD Buyer Survey results and cuts to the 2018 to 2022 estimates.</li><li>                  Snap shares are&nbsp;<font color='red'>down 2.9%</font>&nbsp;premarket to $14.86.<br />   &nbsp;</li></ul><div class=\"tiny-share-widget\" data-id=\"3321115\" data-linked=\"Snap -2.9% after analyst downgrade, price target reduction\" data-tweet=\"$SNAP - Snap -2.9% after analyst downgrade, price target reduction https://seekingalpha.com/news/3321115-snapminus-2_9-after-analyst-downgrade-price-target-reduction?source=tweet\" data-url=\"https://seekingalpha.com/news/3321115-snapminus-2_9-after-analyst-downgrade-price-target-reduction\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  7:23 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>20&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3321112\" data-ts=\"1515068367\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/BLFS\" target=\"_blank\">BLFS</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3321112-biolife-solutions-announces-preliminary-2017-revenue-and-2018-guidance\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">BioLife Solutions announces preliminary 2017 revenue and 2018 guidance</a></h4><ul><li>BioLife Solutions&nbsp;(NASDAQ:<a href='https://seekingalpha.com/symbol/BLFS' title='BioLife Solutions, Inc.'>BLFS</a>)&nbsp;<a href=\"https://seekingalpha.com/pr/17037601-biolife-solutions-announces-preliminary-2017-revenue-increase-34-percent-11-million\" target=\"_blank\">announces</a> preliminary Q4 and FY2017 revenue and financial guidance for 2018.</li>                  <li>Preliminary revenue for the Q4 and FY17 was $3.1M and $11M respectively, with year-end cash balance of $6.7M.</li>   <li>Management has issued financial guidance for 2018 as follows:</li><li>Biopreservation media revenue in the range of $13.6M - $14.7M.</li><li>Gross margin of 62% - 64%.</li><li>Operating expenses of $9M - $9.5M.</li><li>Shares are up&nbsp;<font color='green'>3%</font>&nbsp;premarket&nbsp; on light volume.</li>   </ul><div class=\"tiny-share-widget\" data-id=\"3321112\" data-linked=\"BioLife Solutions announces preliminary 2017 revenue and 2018 guidance\" data-tweet=\"$BLFS - BioLife Solutions announces preliminary 2017 revenue and 2018 guidance https://seekingalpha.com/news/3321112-biolife-solutions-announces-preliminary-2017-revenue-and-2018-guidance?source=tweet\" data-url=\"https://seekingalpha.com/news/3321112-biolife-solutions-announces-preliminary-2017-revenue-and-2018-guidance\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  7:19 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3321113\" data-ts=\"1515068304\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/ATRA\" target=\"_blank\">ATRA</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3321113-atara-prices-stock-offering-18_25\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Atara prices stock offering at $18.25</a></h4><ul><li>Atara Biotherapeutics (NASDAQ:<a href='https://seekingalpha.com/symbol/ATRA' title='Atara Biotherapeutics'>ATRA</a>) <a href=\"https://seekingalpha.com/pr/17037504-atara-biotherapeutics-announces-pricing-public-offering-common-stock\" target=\"_blank\">prices </a>its public offering of 7M shares of common stock at $18.25 per share. Underwriters over-allotment is an additional 1.05M shares. Closing date is January 8.</li><li>Yesterday's close was $19.25.</li></ul><div class=\"tiny-share-widget\" data-id=\"3321113\" data-linked=\"Atara prices stock offering at $18.25\" data-tweet=\"$ATRA - Atara prices stock offering at $18.25 https://seekingalpha.com/news/3321113-atara-prices-stock-offering-18_25?source=tweet\" data-url=\"https://seekingalpha.com/news/3321113-atara-prices-stock-offering-18_25\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  7:18 AM </div></div></li>","count":75,"message":null,"success":true,"today":{"start":1577077200,"end":1577163599,"str":"Monday, December 23, 2019"},"yesterday":{"start":1576990800,"end":1577077199}}